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ABSTRACT OF THE DISSERTATION
THE EFFECT OF STIGMA ON TREATMENT ADHERENCE AMONG HIV
POSITIVE ALCOHOL USERS IN HAITI
by
Muni Balakrishnan Rubens
Florida International University, 2016
Miami, Florida
Professor Jessy G. Dévieux, Major Professor
Haiti reports the second highest prevalence of HIV among the Caribbean nations.
People living with HIV/AIDS (PLWH) report stigmatic experiences, inadequate social
support, depression, and anxiety, thereby affecting treatment adherence. This study
examined the relationship between HIV-related stigma and treatment adherence,
considering the effects of depression, anxiety, social support, and coping.
The current study is a secondary analysis of baseline data collected from 362
PLWH from Haiti. The measures included: Community Programs for Clinical Research
on AIDS (CPCRA) adherence questionnaire; Perceived Stigma scale; Brief COPE
questionnaire; State-Trait Anxiety Inventory (STAI); Centers for Epidemiological Studies
Depression Scale (CES-D); and modified Medical Outcome Study Social Support Survey
(mMOS-SSS). Descriptive statistics were used for demographic characteristics. T tests,
Person correlations, multivariable linear regressions and structural equation modeling
(SEM) were used for estimating the strength of associations and mediating effects.
Mean age of the sample was 35.72±8.50 years and 37.0% were men. The mean
self-reported treatment adherence was 93.1 percent. About 50.2% reported high levels of
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perceived stigma, 58.1% reported high levels of social support, 51.1% reported high
levels of coping, 45.6% reported depression and 47.2% reported anxiety. Multivariable
regression showed that treatment adherence was directly associated with quality of care
satisfaction scores (Beta = .032, p = .041) and inversely associated with perceived stigma
(Beta = -0.049, p = .031). Depression was directly associated with perceived stigmapublic view (Beta = 1.877, p = .037) and inversely associated with tangible/informational
social support (Beta = 1.877, p = .020). SEM analyses showed significant associations
between perceived sigma and coping (Beta = .175, p = .003), perceived sigma and
anxiety (Beta = .164, p = .005), coping and anxiety (Beta = .229, p <.001), and anxiety
and treatment adherence (Beta = -.140, p = .018). Maladaptive coping mediated the
relationship between stigma and anxiety levels which in turn adversely affected treatment
adherence.
In summary, HIV-related stigma was associated with lower levels of treatment
adherence, and higher levels of depression and anxiety. These findings could be
informative for future large scale studies on stigma, coping, anxiety and depression and
planning effective interventions for improving treatment adherence.
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CHAPTER I: Introduction and Specific Aims
HIV and Stigma
From the very onset of the pandemic, HIV/AIDS has been associated with
increased stigma (Parker & Aggleton, 2003; Scambler, 2003). HIV/AIDS has been
associated with stigmatized groups such as men who have sex with men (MSMs),
commercial sex workers and injection drug users (IDUs; Parker & Aggleton, 2003). In
spite of evidence of higher HIV transmission rates through heterosexual contacts
globally, MSMs and IDUs have been implicated for acquiring and transmitting the
disease (Lekas, Siegel, & Leider, 2011; Liamputtong, 2013). Even among heterosexuals,
HIV/AIDS has been stereotypically associated with commercial sex work, and women
bear the brunt of stigmatization and discrimination. These discriminatory acts have in
many instances violated human rights and extended to extreme forms of physical and
mental abuse (Deacon et al., 2005). As Mann and Tarantola (1998) have suggested,
“those who – before the arrival of HIV/AIDS – were socially marginalized, stigmatized
or discriminated against, were found gradually and increasingly to bear the brunt of the
HIV/AIDS epidemic. Human rights violations are now recognized to be primordial root
causes of vulnerability to the epidemic” (Mann & Tarantola, 1998, p. 8).
It has been repeatedly stated that HIV/AIDS because of its very nature of
transmission initiates a high level of stigmatization and discrimination (Brimlow, Cook,
& Seaton, 2003; Lekas et al., 2011; Parker & Aggleton, 2003). Thomas (2006) has
described this process as a devaluation based on stereotyping and prejudice, where
individuals tend to degrade those affected as “discreditable or unworthy, resulting in the
person experiencing stigma becoming discounted or tainted” (Thomas, 2006, p. 3175).
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Stigma also includes the individual’s fear and perceived threat about being discovered
about the stigmatizing condition by the family or the community (Sivaram et al., 2009).
Parker and Birdsall (2005) have explained this arm of stigma as prejudiced identity that
sets apart affected individuals or groups because of their self-perceived and heightened
negative perceptions and values towards their disease or condition (W. Parker & Birdsall,
2005).
Deng and colleagues (2007) have also identified stigma as a social construct
resulting from cultural, historical, social, and situational factors subjecting the affected
individuals to feelings of shame or guilt. One of the major products of stigmatization is
discrimination where a stigmatized individual is judged unfairly or unjustly due to the
perception that the individual is at fault for his/her condition (Deng, Li, Sringernyuang, &
Zhang, 2007). HIV/AIDS has also been misconstrued as a disease that affects the
individuals who have breached the moral and ethical standards of divine justice and
threatened the very ethical and moral standards of the society (Zhou, 2007). Stigma may
be expressed as verbal abuse, gossip, isolation, humiliation, rejection or neglect of
individuals (Deng et al., 2007; Thomas, 2006). These manifestations may increase over
time and become consolidated by ignorance, inaccurate information, and misconstrued
perceptions about the disease by the infected population as well as the public
(Apinundecha, Laohasiriwong, Cameron, & Lim, 2007; Sweat & Levin, 1995; Zhou,
2007).
Background
Since the first case of AIDS was identified in 1981 and human immunodeficiency
virus (HIV) was identified as the causative agent, this disease has become a leading cause
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of mortality and morbidity worldwide (Centers for Disease Control and Prevention
[CDC], 1981; Gallo et al., 1984). In the year 2013, global estimation showed that
approximately 35 million people were living with HIV infection (World Health
Organization [WHO], 2015a). Since the initial identification and characterization of the
disease, about 78 million people have become infected and 39 million people have died
from AIDS and related conditions (Joint United Nations Programme on HIV/AIDS
[UNAIDS], 2014a). About 2.1 million people have become newly infected with HIV in
the year 2013 (UNAIDS, 2014b).
Since the advent of antiretroviral medications, HIV infection has become a
chronic disease with decreasing incidence and increasing prevalence. There were 29.8
million people living with HIV in 2001, and in 2014 the number has increased to 36.9
million. However, the global prevalence rate (percentage of people 15-49 years old who
are infected) has leveled since 2001 and was 0.8% in 2014 (UNAIDS, 2015c). In the year
2013, about 12.9 million people were receiving some form of antiretroviral medication
and constituted only 37% of all infected cases globally (UNAIDS, 2014d). According to
the global estimates, about $19.1 billion were spent on HIV/AIDS and related conditions
in the year 2013 (Kaiser Family Foundation, 2014). This is a great burden on both
developed as well as developing economies because more than 50% of these total
expenses are directed towards underdeveloped nations with decreased productive
capacity and increased HIV associated life loss years. Haiti is one such Caribbean nation
with the second highest prevalence of HIV among Latin America and the Caribbean and
also the highest number of people living with HIV (PLWH) in this geographical area.
UNAIDS estimated that about 150,000 people are living with HIV in Haiti and
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prevalence among adults between 15-49 years is 2.2 percent (UNAIDS, 2013e). Haiti
also reported 7,500 AIDS related deaths in 2012 (WHO, 2012b). The epidemiological
severity of HIV/AIDS in Haiti is further complicated by many factors such as limited
availability of antiretroviral therapy (ART), non-compliance to ART, substance abuse
and stigma associated with the disease (Boulle & Ford, 2007; Castro & Farmer, 2005;
Young, Wheeler, McCoy & Weiser, 2014).
Stigma and Discrimination
Individuals coping with chronic illnesses have always been perceived as weak,
dependent, or a burden on society. Many illnesses are associated with irresponsible or
poor lifestyle choices (Millen & Walker, 2000). HIV/AIDS is one such disease and
research has consistently found that HIV/AIDS is far more stigmatizing than other
chronic illnesses such as cancer, diabetes, heart disease or infectious diseases like
tuberculosis and leprosy because of its association with homosexuality (Liamputtong,
2013).
The word stigma is derived from ancient Greek, meaning “mark” (Jones, 1987).
Stigma has always produced negative impacts on the life, health and well-being of the
individuals subjected to it (Liamputtong, Fanany, & Verrinder, 2012). Stigma has its
basis in “differences” in age, gender, race, socioeconomic status, disability, appearance,
personality, illness, color, sexuality and specific behaviors which evoke panic,
abhorrence, discontent or pity from individuals belonging to the same or other population
groups (Whitehead, Carlisle, Watkins, & Mason, 2001). The main element of
stigmatization strategies includes social schism to create a “them and us” divide and lay a
foundation for classification of individuals as “good and in favor” or “bad and out of
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favor” within a given socio-political setting (Foucault, 1973; Whitehead et al., 2001, p.
89).
Stigma also shows the phenomenon of self-perpetuation once the initiation of this
socio-political schism occurs. The factors that aid in perpetuating stigma include
prejudice, religious beliefs, social norms, superstition, ignorance, lack of knowledge and
transmission of beliefs and thoughts across succeeding generations (Deacon, Stephney, &
Prosalendis, 2005). Sontag (1991) suggested that HIV/AIDS has been associated with the
“sinful” and “evil,” and PLWH are branded as “immoral” and “depraved” (Sontag, 1991,
p. 90). As a consequence, they are socially unrecognized and considered as “not one of
us” leading to discrimination (Whitehead et al., 2001, p. 126).
Multidimensional Aspects of HIV-Related Stigma
Though there are many arms of HIV-related stigma, they have been broadly
classified into three subtypes (Bond, Chase, & Aggleton, 2002; Thomas, 2006;
Vanlandingham, Im-Em, & Saengtienchai, 2005). ‘Internalized stigma’ occurs due to
self-blame and self-deprecation by the individuals themselves because of their perceived
beliefs and knowledge about the acquisition of the disease. ‘Anticipated stigma’ relates to
the fear of being discriminated by willful or accidental disclosure of the disease condition
resulting in constant avoidance or concealment of the disease, as well as the anxiety
associated with the accidental disclosure of the disease. ‘Enacted stigma’ occurs because
the individuals have experienced tangible discriminatory acts from non-infected
individuals which could be actual or perceived. However, Parker and Aggleton (2003)
have suggested that stigma may manifest in varied forms specific to the sociocultural
context of the individuals, and the accompanying discrimination also varies across
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cultural diversities and complexities (Parker & Aggleton, 2003). Zhou (2007)
recommends that sociocultural beliefs, moral beliefs and values within local contexts
should always be considered to better understand the factors affecting stigma and
discrimination in a given community. Stigma also changes temporally and therefore the
currently accepted dimensions related to stigma will not absolutely represent the
established dimensions in the past or the evolving dimensions in the future. Thus stigma
and discrimination constitute a continuously evolving phenomenon (Zhou, 2007).
HIV Stigma and Treatment Adherence
ART has been the most critical determinant of control over HIV viral RNA and
HIV/AIDS related conditions (Bangsberg et al., 2000; Bangsberg et al., 2001; Paterson et
al., 2000). Many studies have positively associated ART adherence and cognitive
processes such as knowledge, perception and health literacy (Maggiolo et al., 2002;
Mehta, Moore, & Graham, 1997). Recent studies have also associated lack of ART
adherence with structural barriers such as geographic isolation, lack of transportation,
food insecurity and lack of money and resources for treatment alternatives (Hardon et al.,
2007; Kalofonos, 2010; Nagata et al., 2012; Pyne-Mercier et al., 2011; Taiwo et al.,
2010; Weiser et al., 2010).
HIV/AIDS related stigma is another barrier that adversely affects many aspects of
HIV-related care including HIV testing, HIV serostatus disclosure and ART adherence
(Cree, Kay, Tisdall, & Wallace, 2004). The process of enacted stigma and perceived
stigma prevent the patient from seeking active medical services and force them towards
concealing their seropositive status or refusing to be tested and treated (Bond et al., 2002;
Thomas, 2006). Despite substantial evidence of stigma acting as a barrier in effective
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management of HIV in several populations worldwide, the mechanisms through which
stigma compromises ART adherence in Haitian HIV positive alcohol users needs further
explorations. This is an important gap in the literature which needs to be filled in order to
improve treatment outcomes and the quality of life in these HIV positive patients.
HIV-Related Stigma and Depression
HIV-related stigma produces feelings of shame, guilt and concern regarding the
disclosure, which in turn results in negatively perceived self-image. Such negative
attitudes and perceptions can exacerbate mood disorders such as major depressive
disorder, anxiety and panic attacks, and obsessive compulsive disorders (Chandra,
Deepthivarma, Jairam, & Thomas, 2003; Whetten, Reif, Whetten, & Murphy-McMillan,
2008). HIV also produces feelings of self-loathing, guilt and shame among people
diagnosed with the condition (Emlet, 2007). In extreme forms, these feelings could be
transformed into intense depression and despair; PLWH often report extreme social
withdrawal and acceptance of impending death (Hong, Anh, & Ogden, 2004). When
compared to the general population, PLWH report 2-3 times increased rates of depressive
disorders (Mogga et al., 2006). This could be especially true in underdeveloped countries
such as Haiti where the prevalence of depressive disorders is as high as 41.7% in the
general population (Surkan et al., 2010; Wagenaar, Hagaman, Kaiser, McLean, & Kohrt,
2012; Dévieux et al., 2013). Depressive disorders have been associated with many
adverse health-related outcomes such as poor adherence to medications, faster
progression to AIDS and poor quality of life in HIV positive patients (Ammassari et al.,
2004; Bouhnik et al., 2005; Treisman & Angelino, 2007; Malow et al., 2013).
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HIV-related stigma, gender, lower education, unemployment, compromised
immune status, and increased rate of opportunistic infections are some of the variables
associated with depression in HIV positive patients (Burack et al., 1993; Leserman et al.,
2000; Olley, Seedat, Nei, & Stein, 2004; Sherbourne et al., 2014; Simbayi et al., 2007).
Additionally, HIV-related stigma adversely affects health service utilization and
psychological well-being (Bond et al., 2002; Chesney & Smith, 1999; Lichtenstein,
Laska, & Clair, 2002). In spite of profound effects on general well-being and quality of
life, HIV-related stigma has often been overlooked in many scientific studies
(MacQuarrie, Eckhaus, & Nyblade, 2009). Similarly, major depressive disorders have
also been associated with compromised immunological and virological variables such as
lower CD4 counts and uncontrolled viral load (Olley et al., 2004). Major depressive
disorders have been associated with female gender, younger age and unemployment
status (Akena, Musisi, & Kinyanda, 2010; Nakimuli-Mpungu, Musisi, Mpungu, &
Katabira, 2006). Many of these factors may have a bearing on treatment outcomes in
PLWH.
Current Study
Using secondary data from the parent study titled “Intervening with Haitian HIV
positive Alcohol Users: An Environmental Psychosocial Framework,” the current
dissertation examined the effect of stigma on HIV treatment adherence. This study
examined the effects of HIV-related stigma on coping strategies affecting medication
adherence and anxiety. In addition, this study also examined the relationship between
depression and HIV-related stigma. The parent study was an adapted randomized
controlled trial of a Cognitive-Behavioral Stress Management (CBSM-A) intervention for
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simultaneously enhancing safer sex practices, adherence to ART medication, and
reducing alcohol or other drugs use, in a predominantly poor urban population in Haiti.
The parent study included 389 alcohol using, HIV positive individuals. The experimental
group was administered the CBSM-A, an adapted intervention guided by the
Information-Motivation-Behavioral Skills (IMB) theory. The intervention used a smallgroup design for HIV positive alcohol-using populations, which also addressed their
cognitive/self-management and coping barriers that could impede sustainable outcomes,
particularly in resource-constrained settings such as Haiti. In the parent study, the CBSMA intervention was compared with a wait-list control group where participants received
the intervention following their 6-month follow-up assessment.
The following aims and hypothesis were tested in this study:
Aim 1: To understand the relationship between HIV-related stigma and HIV treatment
adherence in a sample of HIV positive alcohol users in Haiti.
Research Question 1: Does HIV-related stigma significantly affect HIV treatment
adherence in a sample of PLWH in Haiti?
Hypothesis 1: Among PLWH, levels of HIV-related stigma will be significantly
associated with levels of HIV treatment adherence.

Aim 2: To understand whether coping strategies act as a mediator between HIV-related
stigma and HIV treatment adherence.
Research Question 2: Do coping strategies used to deal with HIV-related symptoms
mediate the relationship between HIV-related stigma and HIV treatment adherence?
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Hypothesis 2: Among PLWH, coping strategies act as a mediator between HIV-related
stigma and HIV treatment adherence.

Aim 3: To understand whether coping strategies act as a mediator between anxiety and
HIV treatment adherence
Research Question 3: Do coping strategies used to deal with HIV-related symptoms
mediate the relationship between anxiety and HIV treatment adherence?
Hypothesis 3: Among PLWH, coping strategies act as mediator between anxiety and
HIV treatment adherence.

Aim 4: To understand the relationship between HIV-related stigma and depression
Research Question 4: Does HIV-related stigma significantly affect depression in
PLWH?
Hypothesis 4: Among PLWH, HIV-related stigma will be significantly associated with
higher levels of depression.

Aim 5: To understand whether social support acts as a mediator between HIV related
stigma and depression symptoms
Research Question 5: Does social support mediate the relationship between HIV related
stigma and depression?
Hypothesis 5: Among PLWH, social support will act as a mediator between HIV related
stigma and depression.
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Theoretical framework
Stress and coping theories provide frameworks to relate how individuals cope and
react to psychologically stressful situations (Matthieu & Ivanoff, 2006). Stigma
represents a stressful psychological situation in which an individual internalizes negative
beliefs, opinions and feelings towards himself/herself (Logie, Newman, Chakrapani, &
Shunmugam, 2012). Evidence indicates that PLWH often accept the stigma associated
with their disease; this acceptance adversely influences their physical and mental health
(Kalichman et al., 2009). Kalichman and colleagues (2009) reported that the stigma
associated with HIV/AIDS could act as significant barriers towards prevention, testing
and care. The study also showed that internalized HIV-related stigma was consistent
across PLWH from geographically diverse locations such as South Africa, Swaziland and
Atlanta, GA, U.S. This study also reported that the social stigma of HIV/AIDS follows
the classic model of stigma identified by Goffman’s seminal 1963 study. Goffman
defined three dimensions of stigma relating to flaws in personal character and include:
disgraced social identity; physical abnormalities or defects; and racial stigma (Goffman,
1963). Green (1995) in a street survey among 300 non-infected participants and 42
PLWH in Glasgow and Edinburgh documented these attributes in the general public
(Green, 1995).
Stress theory dates back to Hans Selye’s benchmark research and his book on the
“Stress of Life” (Selye, 1956). A psychosocial stressor refers to the reaction of an
individual to a response or stimulus that he/she perceives as a threat (Matthieu & Ivanoff,
2006). The concept of HIV stigma falls under the definition of a psychosocial stressor.
HIV stigma creates stress from the prejudiced attitudes and discrimination toward
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PLWH. Understanding the stress stimulus allows the ability to target interventions to deal
with this response.
Coping theory encompasses the concept of the adaptation response in an
individual to a stressful situation. Coping involves self-directing endeavors targeted
towards diminishing the harmful effects of stressors (Varni, Miller, McCuin, & Solomon,
2012). Coping strategies may involve approach (engagement) or avoidance
(disengagement) responses to stressors. PLWH using disengagement coping to deal with
stressors show a higher association with depression, anxiety and emotional distress;
whereas PLWH employing engagement coping strategies demonstrate lesser depression
and higher levels of satisfaction with life (Heckman, 2003).
HIV related stigma and coping mechanisms significantly affect many outcome
variables such as HIV treatment adherence, HIV symptomatology and anxiety towards
the disease condition. Furthermore, anxiety disorders among PLWH are eight times
higher than in the general population (Varni et al., 2012). Anxiety and the symptoms of
the disease are also negatively correlated with adherence to the medical regimen. In
addition, another variable, social support, acts as a mediator for the relationship between
depression and HIV related stigma (Rao et al., 2012). Because of the interrelationships
between these variables, depression could also have significant adverse effects on HIV
treatment adherence and anxiety. Figure 1 illustrates the all-encompassing model which
was created to demonstrate this complex interrelationship.
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Figure 1. Stress-coping model demonstrating interrelationship of variables.
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CHAPTER II: Literature Review
From the very onset of HIV/AIDS in the early 1980s, this pandemic has been
considered both a medical and social illness (Herek & Capitanio, 1993; Letteney &
Laporte, 2004). Scambler (2003) stated that HIV/AIDS has always been “both medicalized
as disease and moralized as stigma” (Scambler, 2003, p. 199). Ever since its identification,
HIV/AIDS has provoked powerful reactions from the public such as prejudices against
“sex, drugs, death and contagion” (Scambler, 2003, p. 199). This uniqueness has made
HIV/AIDS an extremely stigmatizing disease. This literature review explores the different
associations and components of HIV-related stigma and its adverse effects.
HIV Related Stigma
The conceptualization of stigma can be traced back to the work of Erving
Goffman, who defined stigma as an "attribute that is deeply discrediting, reduces the
stigmatized individual from a whole and usual person to a tainted, discounted one"
(Goffman, 1963, p. 3). Building on this foundation, many researchers have successively
discredited stigma as a social injustice that involves discriminatory behaviors and indirect
harm to the stigmatized individual (Major & O'Brien, 2005). Link and Phelan (2001)
developed an integrative approach for defining stigma in terms of four core components:
distinguishing and labeling human differences; cultural beliefs perpetuating negative
stereotypes; categorization of labeled persons in order to develop separation mentality
(i.e. "us" versus "them"); and finally, status loss and discrimination experienced by
labeled persons resulting in social injustice (p. 367). This definition also encompasses the
broader forces acting in the stigmatization process, particularly social, economic, and
political (Link & Phelan 2001, p. 367). Though personal responses to stigma significantly
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vary from individual to individual, self-stigma has been defined as the situation wherein
individuals internalize and accept stigma-related devaluations and discriminations
(Herek, 1990). The negative thoughts and feelings that result from these internalization
processes lead to the creation of self-hatred and has been linked to increased depression,
psychological distress, and decreased reliance on social support (Mak et al., 2007; Lee,
Kochman, & Sikkema, 2002).
HIV-related stigma constitutes one of the significant barriers adversely affecting
treatment adherence and thereby increasing transmissions rates of the disease (Katz et al.,
2013). HIV-related stigma has been identified as a social and structural phenomenon that
involves stereotyping, status loss, and discrimination in many power structure settings
existing in complex societies (Mahajan et al., 2008). Studies show that the most salient
domains of HIV-stigma (that affect self-esteem and self-acceptance in PLWH) include
blame, stereotypes, and fear of contagion (Sayles et al., 2007). Stigma is thus a complex
social process (Earnshaw & Caudoir, 2009), with varied and profound implications,
particularly for PLWH (Lee, Kochman, Sikkema, 2002). HIV-related stigma has been
linked to the creation and maintenance of social inequalities, often along the lines of race,
class, gender, and sexual orientation (Parker & Aggleton, 2003). This is additionally
complicated by stigmas related to drug use, and homosexuality (Reidpath & Chan, 2005;
Crawford, 1996). Moreover, several studies have shown that HIV-related stigma is more
intense when compared to the stigmas associated with other illnesses such as herpes,
cancer, tuberculosis etc. (Peters et al., 1994). HIV-related stigma has significant effects
not only on the diagnosed individuals, but also their family members (Bogart et al.,
2008), their health workers and volunteers (Snyder et al., 1999).
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Earnshaw and Chaudoir (2009) developed the HIV Stigma Framework to
understand the specifics as well as the effects of stigma experienced by PLWH. The HIV
Stigma Framework proposes three distinct stigma mechanisms: internalized, anticipated,
and enacted HIV stigma categories (Earnshaw & Chaudoir, 2009). Many studies have
utilized this framework to investigate stigmatic experiences among PLWH.
Internalized Stigma: The PLWH tend to endorse the negative feelings and beliefs of
others and internalize these feelings to themselves thus leading to internalized stigma. In
a study on internalized stigma, Lee, Kochman, and Sikkema (2002) found that the
majority of those having internalized stigma were diagnosed more recently; were
receiving less support and acceptance from their families; knew fewer people with HIV;
and were less likely to participate in HIV support groups. People experiencing higher
levels of internalized stigma worry more about spreading their infection to others and
report higher levels of hopelessness, anxiety and other depressive symptoms (Lee,
Kochman, Sikkema, 2002). Among PLWH, internalized stigma generates feelings of
shame and guilt and the affected individuals see themselves as dirty/unclean and
deserving of the negative outcomes enforced upon them (Earnshaw et al., 2013).
Anticipated Stigma: HIV stigma also manifests as anticipated stigma, wherein PLWH
anticipate negative attitudes, treatment complications, and acts of discrimination because
of their very HIV positive status (Earnshaw et al., 2013). Research shows that
experiencing this type of stigma is associated with increased physical illness (Quinn &
Chaudoir, 2009) and stress related symptoms (Pascoe & Richman, 2009).
Enacted Stigma: The third category, enacted stigma, includes the actual experiences of
stereotyping, discrimination, social exclusion, and other forms of prejudices enforced by
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others on the person experiencing the stigmatic condition (Earnshaw, et al., 2013).
Enacted stigma among PLWH has been associated with poor health outcomes, in terms of
both physical and psychological well-being (Earnshaw et al., 2015; Logie & Gadalla,
2009). Enacted stigma has been associated with worsening HIV progression such as
lower CD4 counts, uncontrolled viral load, opportunistic infections and faster progression
to AIDS (Earnshaw et al., 2013; Holzemer et al., 2007). Despite advances in treatment
and management of HIV/AIDS and ongoing educational campaigns, the misconceptions
held by the public regarding the contagion still persist, leading to greater instances of
enacted stigma (Ware, Wyatt, & Tugenberg, 2006).
HIV and Mental Health
It has long been recognized that PLWH face significant psychosocial challenges
often resulting in complex mental health issues (Catalan, Burgess, & Klimes, 1995).
Many researchers have also suggested that PLWH experience greater psychological
distress when compared to the general population (Stutterheim et al., 2009). However,
psychiatric illnesses among these patients have often being under reported (Gatz,
Brownstein, & Taylor, 2005). Many studies on the health challenges faced by PLWH
identify mental health problems as one of the most common comorbidities associated
with HIV (Edmiston, Passmore, Smith, & Petoumenos, 2015; Kendall et al., 2014). After
comparing clinico-psychological reports of PLWH over a period of 24 years, Adams and
colleagues (2016) reported that though acute mental health syndromes and organic brain
disorders have declined, depression and anxiety disorders (often chronic) have increased
over the years. Additionally, new mental health problems related to recreational drug use
and co-infections (e.g. HIV and Hepatitis C) are increasing among PLWH, justifying the

26

continued need for increased mental health services for this population (Adams et al.,
2016). Ironically, mental health research and treatment facilities for HIV positive patients
are lacking, especially in resource limited settings such as Haiti (Dow et al., 2016; Klasen
& Crombag, 2012; Castro & Farmer, 2005). The majority of PLWH are already
vulnerable to mental health problems. PLWH living in resource limited settings have
additionally elevated risks for anxiety disorders, PTSD, depression (Betancourt et al.,
2014; Seth et al., 2014; Malow et al., 2013) and suicidal ideations (Marzuk et al., 1997)
compared to the general population. PLWH in mid- to later-life also face specific
challenges such as emotional distress and suicidal thoughts and require targeted and longterm interventions and psychiatric care (Kalichman et al., 2000; Heckman, 2000;
Heckman, 2002).
Stigma and Mental Health among PLWH
HIV-related stigma represents a significant risk factor for mental health problems
among PLWH (Earnshaw & Chaudoit, 2009). Research has consistently shown that
higher levels of stigma are associated with lower levels of mental health in PLWH (Logie
& Gadall, 2009). HIV-based discrimination and prejudice have serious impacts on
psychological health (Steward et al., 2011), with stigma experiences being linked to
depression, anxiety, and risky sexual behaviors (Vanable et al. 2006; Preston et al.,
2007). Some researchers have conceptualized that the psychological and emotional
challenges such as illness, fear of death, poverty, and social isolation lead to “chronic
sorrow” and stigma additionally aggravates these factors in PLWH (Lichtenstein, Laska,
& Clair, 2002). They have also recommended that stigma should be considered as a
potential marker for psychiatric problems, specifically chronic depression.
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The effects of HIV-related stigma become additionally detrimental when multiple
types of stigmas act in combination – for instance race- or sexual orientation-based
stigma combined with fear of contagion stigma. Lelutiu-Weinberger and colleagues
(2015) in their study on men who have sex with men (MSM) of color have highlighted
the adverse effects of these types of combined stigmas. Their study showed that there are
many adverse mental health outcomes associated with each individual type of stigma.
The adverse outcomes associated with each specific stigma additively combine together
when multiple stigmas are simultaneously acting on these individuals, thereby increasing
their risks for mental, emotional, and psychological problems (Lelutiu-Weinberger et al.,
2015; Balsam et al., 2011; Stirratt et al., 2008). The negative mental health outcomes of
compounded stigmas have been reported in many minority populations. For example,
minority PLWH in the U.S. who experienced discrimination due to age (Emlet et al.,
2015; Emlet, 2006) or race (Singleton, et al. 2015) when compounded with other specific
stigmas showed higher susceptibilities to mental health problems.
Anxiety, Stigma & Treatment Adherence
The burden of social and physical coping mechanisms used by the PLWH to
manage their diseased states are worsened due to stigma and discrimination experienced
by this population (Colbert et al., 2010). Though there are many mental health problems
experienced by this population, depression and anxiety predominate (Sunderland et al.,
2010). Anxiety disorders among PLWH have been associated with stigma and
discrimination and some studies have suggested that HIV-related stigma leads to social
isolation, fear, and other negative emotional consequences exacerbating anxiety disorders
(Fullilove, 1989). Stigma has been identified as a predisposing factor for many anxiety
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disorders (Katz & Nevid, 2005). Affective disorders such as generalized anxiety disorder,
panic disorder, major depressive disorder, post-traumatic stress disorder, and dysthymia
are two to three times more common in PLWH experiencing higher levels of stigma
(Safren et al., 2003; Adewuya et al., 2009). Among PLWH, the prevalence of anxiety
disorders varies from 20% to as high as 47% (Els et al. 1999; Celesia et al., 2013; Vitiello
et al., 2003; Olagunju et al., 2012). While anxiety disorders may pre-exist among those
diagnosed with HIV, it is generally exacerbated during stressful phases such as HIV
diagnosis and coping, implicated largely in fear of death as well as HIV-related stigma.
Emotional dysregulation among PLWH also contributes to greater anxiety and distress
(Brandt et al., 2013). Moreover, HIV-related anxiety adversely affects general health
outcomes in PLWH and has been associated with decreased life satisfaction scores, faster
disease progression, and lower treatment adherence (Turner et al., 2003; Tucker et al.,
2003; Tsao et al., 2004). Increased anxiety levels have been associated with sub-optimal
treatment adherence in many studies (Panigrahi, Swain, & Mohanty, 2015; Pappin,
Wouters, & Booysen, 2012; Celsia et al., 2010). Van Servellen and colleagues (2002)
found that anxiety scores among HIV positive patients were significantly related to both
self-reported non-adherence and clinically evaluated non-adherence. In another study,
anxiety symptoms were associated with lower treatment adherence and compliance to
ART schedules (Schönnesson et al., 2007). Even among PLWH without any diagnosed
psychiatric illness, anxiety was found to be the most significant variable associated with
sub-optimal treatment adherence (Schönnesson et al., 2007). This evidence strongly
suggests that there is an adverse relationship between anxiety and HIV treatment
adherence. Though there are many studies on the beneficial effects of reducing anxiety on
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treatment adherence in other populations (Kemppainen et al., 2006), similar studies are
lacking in Haitian PLWH. There is still a considerable gap in the literature regarding the
effects of discrimination and anxiety disorders on HIV treatment adherence in
marginalized populations such as Haitian PLWH.
Depression and HIV
Depressive disorders constitute the most common mental illness among PLWH
(Choi, 2013) and have significant effects on interpersonal relationships, employment,
quality of life, treatment adherence and survival (Kibret & Salilih, 2016). After being
diagnosed with HIV, PLWH often struggle to adapt to the chronic disease condition, and
suffer from depression and anxiety as they attempt to make sense of their current
situation and come to terms with the social, mental, and physical challenges of the
disease (Williams, et al., 2005; Green & Smith, 2004). A meta-analysis done by Ciesla &
Roberts (2001) showed that the prevalence of major depressive disorders was nearly
double among PLWH when compared to HIV-negative counterparts. Irrespective of these
findings, studies continue to suggest that depression is under-diagnosed and underreported among PLWH (Rodkjaer, Laursen, Balle, & Sodemann, 2010). Depression has
also been associated with impaired immunological responses and higher mortality rates
(Sumari-de Boer, Sprangers, Prins & Nieuwkerk, 2012; Ironson et al., 2005). There is a
definite need for understanding the prevalence of these disorders in PLWH. Bouhnik and
colleagues (2005) suggested that depression on its own adversely affected clinical disease
progression in PLWH, independent of the adverse effects of sub-optimal treatment
adherence associated with depression. Cook et al. (2004) additionally found that AIDSrelated deaths were more likely among female PLWH with chronic depressive disorders
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after controlling for many other factors. Studies have also reported that there is a direct
relationship between severity of clinical depression and clinical disease progression in
PLWH which strengthens over time (Lyketsos et al., 1996; Wells et al., 1989).
HIV Treatment Adherence
Treatment adherence is a complex concept involving many domains: the patient;
the disease; the medical care settings including treatment, relationship to caregivers, and
the wider healthcare system; and the socio-cultural context (Ammassari et al., 2002). Due
to its broad domains, it is very challenging to identify and target all the potential
determinants of treatment adherence. Yet, it is crucial because many studies have
recommended moderate to high levels of adherence to ART to achieve adequate control
over the disease (Kobin & Sheth, 2011; Parienti et al., 2008; Shuter et al., 2007). HIV
treatment typically involves a complex regimen of several pills consumed multiple times
in a day. Some of the factors influencing HIV treatment adherence include: memory;
adverse effects of medications; regimen complexity; domestic responsibilities;
availability and access to medications; existing comorbidities; psychiatric problems such
as depression and anxiety; and subjective knowledge and awareness about the disease
(Gifford et al., 2000). Because of several factors involved, it would be beneficial to
consider treatment adherence from a biosocial perspective. In biosocial approaches,
analyses and interpretations are based on broader considerations of both the clinical and
social factors affecting adherence and the dynamic interactions of these processes over
time (Singer, 2003). Gaining insight into the particular socio-cultural contexts in which
HIV treatment is occurring, and acknowledging the dynamic nature of such contexts
would be useful in developing a more grounded understanding of the multiple and
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evolving factors associated with adherence and non-adherence behaviors (Spire et al.,
2002; Ickovics & Meade, 2002). Treatment non-adherence among PLWH is thus a
complicated and evolving issue of great importance. Non-adherence in HIV patients can
lead to uncontrolled viral loads which in turn could increase the risk for sexual
transmission as well as drug resistant viral strains (Lucas, 2005). Many studies have
shown that effective and consistent adherence to ART decreases the risk of sexual
transmission among sexual partners (Cohen et al., 2011).
HIV Treatment Adherence and Mental Health
As previously discussed, depression, anxiety and other mental health problems are
highly prevalent among PLWH (Kilbourne et al., 2002) and have consistently been
implicated for lower treatment adherence (Gonzalez et al., 2011; Turner et al., 2003).
Non-adherence to HIV treatment is estimated to be three times greater among those with
depression when compared to those without (DiMatteo, Lepper, & Croghan, 2000). Some
of the factors associated with depression that may contribute to non-adherence include:
sense of hopelessness; negative expectations; and pessimistic thoughts. Additionally,
depressed individuals often have decreased social interactions, which, in the context of
treatment adherence, may limit their access to some of the contacts necessary for
maintaining compliance (both emotional and practical; Starace et al., 2002). In a
longitudinal study, it was found that participants who reported depression during the
baseline visit showed a two-fold decrease in treatment adherence during the follow-up
after adjusting for covariates, thus underscoring the dynamic rather than static
relationship between depression and treatment adherence (Kacanek et al., 2010). Yun and
colleagues (2005) showed that HIV patients who adhered to antidepressant medications
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also adhered to ART. However, this could have been due to higher adherence to all
medications in general rather that the effects of anti-depressants on ART adherence.
Similarly, in a large scale clinical study consisting of 3,359 PLWHs reporting depression,
Horberg and associates (2008) found that greater adherence to selective serotonin
reuptake inhibitor (SSRI) class of antidepressants was associated with improved HIV
treatment adherence in terms of controlled viral load and recuperating CD4 T-cell counts.
Many other studies have also reported improved HIV treatment adherence in PLWH
receiving psychotherapeutic treatment (cognitive-behavioral therapy) for their depression
(Safren et al., 2009; Weber et al., 2004; Kelly et al., 1993). A recent meta-analysis
suggested that targeted and effective treatments for depression would not only positively
impact adherence, but could also considerably improve quality of life and health
outcomes in PLWH (Sin & DiMatteo, 2014).
HIV Treatment Adherence and Stigma
Stigma has shown to have pervasive negative effects on multiple aspects of HIVrelated care such as willingness and decision to be tested (Chesney & Smith, 1999), HIV
status disclosure (Smith, Rossetto, & Peterson, 2008; Steward et al., 2008), and seeking
social and psychological support (Logie & Gadalla, 2009; Mak et al., 2007). As outlined
earlier, internalized stigma is often associated with maladaptive responses to social,
mental and physical factors related to treatment adherence. In a review that examined
both qualitative and quantitative variables related to stigma and HIV treatment adherence,
it was found that HIV-related stigma adversely affected treatment adherence through
many general and group-specific psychological processes. This review also reported that
adaptive coping and social supports were crucial in determining the success achieved by
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participants in overcoming structural and economic barriers towards effective treatment
adherence (Katz et al., 2013). In a cross sectional study of PLWH in Hong Kong,
researchers also found that higher rates of self-perceived stigma were reported by those
who intentionally did not adhere to treatment regimen when compared to those who
adhered to treatment or those who unintentionally failed to adhere (Mo & Mak, 2009).
Experiences of stigma and discrimination have also been associated with increased odds
of non-adherence in many other studies (Boyer et al., 2011; Li et al., 2010). In summary,
the stress, social isolation, and diminished view of self, emanating from stigma lead to
maladaptive repercussions against treatment regimens and achievable compliance
(Adeyemi, Olubunmi, & Oluseyi, 2011). In contrast to these findings, a number of studies
have also reported that there is no significant association between stigma and HIV
treatment adherence (Martinez et al., 2012; Kalichman et al., 2008).
Alcohol Use and HIV Treatment Adherence
In addition to stigma and mental health problems, alcohol and drug use have been
identified as important factors affecting HIV treatment adherence (Lucas, 2011). Alcohol
use constitutes the most consistent and widespread barrier to HIV treatment adherence
(Gonzalez, Barinas, & O’Cleirigh, 2011; Azar et al., 2010). Alcohol use is not only a
significant cause of sub-optimal treatment adherence but also associated with worsening
disease progression and compromised general well-being (Cook et al., 2001). It has been
estimated that a quarter to half of all PLWH report moderate to higher levels of alcohol
consumption, and many of them cross into the 'problem drinking' category defined as
alcohol consumption "sufficiently large enough to lead to problems of health and social
functioning, but do not necessarily meet Diagnostic and Statistical Manual of Mental
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Disorders, Fourth Edition criteria for alcohol abuse or dependence" (Cooke et al., 2001 p.
83). One study also reported that alcohol use was twice as common in those PLWH who
reported cocaine or heroin use or reported lower educational status (Galvan et al., 2002).
Several studies have reported that alcohol use alone or in combination with drug use have
significantly decreased treatment adherence (Chander, Lau, & Moore, 2006; Cook et al.,
2001). In a study of PLWH with history of alcohol use problems, semiannual assessments
over a period of 30 months revealed that alcohol consumption constituted the most
significant predictor of treatment non-adherence (Samet et al., 2004). This study also
showed that adherence rates were significantly lower in those who continued to use
alcohol when compared to recent abstainers (Samet et al., 2004). Alcohol consumption
during ART resulted in medication lapses, missed doses, and ultimately, treatment
failures in many studies (Hendershot et al., 2009; Braithwaite et al.,2007). Additionally,
alcohol use resulted in memory and cognitive impairments which further affected
treatment compliance (Braithwaite et al., 2005). Excessive alcohol consumption also
affected treatment adherence by delaying follow-up visits, prescription renewals and
medication pick-ups (Kalichman et al., 2007; Sankar et al., 2007).
Coping and Resilience
Being seropositive is an inherently stressful situation with far reaching mental and
psychosocial consequences (Kelly et al., 1998). As medical advances continue to prolong
the lives of PLWH, there is a greater need for understanding the adaptation and coping
mechanisms employed by these patients. When faced with situations of acute/ongoing
stress or the challenges of stigma and discrimination, individuals engage in coping
processes that include behavioral as well as psychological adaptations aimed at
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overcoming the stressors or challenges (Taylor & Stanton, 2007). The coping processes
involve efforts to tolerate or overcome the stressful and painful effects of particular
events (Folkman & Lazarus, 1980). In the context of HIV infection, effective coping is
said to require "conscious, purposeful behavior" which "determines the individual’s
ability to live successfully with the continuous and chronic assault of HIV" (Fife et al.,
2008, p. 77). Studies have identified two general forms of coping: active (or approach
coping) and passive (or avoidance coping; Moosa, Jeenah, & Vorster, 2005; Smith et al.,
2001). Active coping involves directly engaging with situations via problem-solving,
information seeking, and cognitive restructuring processes, whereas passive coping
involves denial and avoidance (Kotzé, et al., 2013).
While either one or both of these coping mechanisms may be employed randomly
or in tandem, studies show that subjects employing active approaches have greater
success rates in adapting to stressors and hence report fewer negative effects compared to
those relying solely on passive avoidance strategies (Kim et al., 2010). Yeji and
colleagues (2014), for example, found that one of the elements of avoidance coping
strategies includes withdrawal from social contacts, which, in their study, increased the
likelihood of depression. Other studies have similarly concluded that passive coping
based on denial and avoidance is linked to higher rates of depression and even impaired
treatment adherence (Lesserman et al., 1997). Passive coping has also been associated
with increased sexual risk behaviors which could lead to increased transmission of the
virus (Kelly et al., 1993). In contrast, a number of studies exploring coping mechanisms
have found that active coping strategies improve quality of life (Vyavaharkar,
Moneyham, Murdaugh, & Tavakoli, 2011), nurture higher self-esteem (Trevino et al.,
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2010; Stein & Rotheram-Borus, 2004) and develop more positive affect (Deichert et al.,
2008). Additionally, studies have also shown that active coping strategies have the
potential to decrease psychological distress (Kraaij et al., 2008) and are associated with
lower levels of substance use (Pence et al., 2008) and greater treatment adherence
(Vervoort et al., 2009). Active coping is considered an adaptive or resilient strategy
because it involves positive means of adaptation and enables beneficial recovery and
resilience to significant stressors (Sinclair & Wallston, 2004). Because of these beneficial
effects, many studies have recommended increasing our collective knowledge about
active coping strategies among PLWH and understanding the factors and resources
influencing these strategies (Earnshaw et al., 2013b).
Resilience refers to the capacity of positive adaptation and effective coping when
faced with stressors and adversities (Connor & Davidson, 2003). The characteristics
associated with resilience may be both individual (e.g. self-esteem, personality traits,
coping style, spirituality, etc.) and social (e.g. supportive peer networks, relationship and
support from family, friends etc.; Zhang et al., 2015). Among PLWH, stigma constitutes
an important cause of stress, anxiety, panic and depression and PLWH are exposed and
forced to cope with it. The notion of “resilience resources” was constructed to identify
the modifiable and strength-based moderators that have effects on the coping
mechanisms adopted by PLWH (Earnshaw et al., 2013b). Among these resources, social
support and identity centrality constitute the two most crucial elements (Earnshaw, et al.,
2015; Pascoe & Smart Richman, 2009).
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Social Support
There is considerable literature about the fundamental role played by social
support in improving mental and physical outcomes in PLWH (Degroote, Vogelaers, &
Vandijck, 2014). Social support (Wallston, Alagna, DeVellis, & DeVellis, 1983) has
been categorized into two broad domains: emotional/informational support (which
includes the expression and exchange of positive feelings and emotions, particularly
empathy, love, and trust) and instrumental/tangible support (which represents the more
tangible forms, such as physical assistance or material goods and services; Earnshaw et
al., 2015; Cho, Zunin, Chao, Heiby, & McKoy, 2012; Taylor, 2011; Heaney & Israel,
2008). Both of these social support components, emotional/informational support and
instrumental/tangible social support, are identified as key resilience resources that
moderate the relationship between stigma and stress (Earnshaw et al., 2015). Social
support has been shown to reduce depression in PLWH (Asante, 2012; Vyavaharkar et
al., 2011) and associated with lower levels of mental health problems (Lam, Naar-King,
& Wright, 2007; McDowell & Serovich, 2007). The emotional/informational support
received from family and friends contribute to the development of adaptive coping and
improved treatment adherence among PLWH (McDowell & Serovich, 2007; Ware,
Wyatt, & Tugenberg, 2006). Instrumental/tangible social support is particularly effective
in coping with depression, improving treatment adherence, and retention in treatment
facilities (Yeji et al., 2014). PLWH with greater access to instrumental/tangible social
support experience less stigma-related stress which may ultimately protect them from
adverse HIV symptoms (Earnshaw, 2015). In fact, Heywood and Lyons (2016) contend
that any kind of support from any of the sources have significant beneficial effects on
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PLWH. Despite evidence of the beneficial effects of social support, some studies contend
that factors beyond social support affect the relationship between HIV stigma and mental
health (Breet, Kagee, & Seedat, 2014). Supporting these contentions, some studies have
also reported that there is no relationship between social support, stigma, stress and
health outcomes (Logie et al., 2012; Pascoe & Smart Richman, 2009).
Identity Centrality
Identity theorists have suggested that selfhood is defined by multiple, shifting
identities which function as internalized positional markers that reflect our participation
in any structured role relationship (Stryker & Serpe, 1982). The various roles that we play
over the course of our lives have significant impacts on our identities and amalgamate
together to develop the self (Serpe, 1987). The salience of any given identity depends on
the numbers, types, and strength of the social relationships associated with that identity,
in the sense that the more a specific identity is invoked and enacted, the higher its
salience (Serpe, 1987). Salience is closely related to another construct, “centrality”,
which refers to the extent to which a particular identity defines an individual's sense of
self and who they are as a person (Quinn & Earnshaw, 2011). For example, being
diagnosed and living with HIV imposes an identity centrality that the affected person
belongs to the HIV infected community. Some studies have postulated that the relative
salience or centrality of HIV status, as a defining aspect of self, may have important
implications for mental health and the coping strategies that individuals adopt as they
deal with various forms of stigma (i.e. enacted, anticipated, internalized; Earnshaw, 2015;
Baumgartner & Niemi, 2013). Significant research has been conducted on the processes
and events that shape the formation of identity centrality for any specific individual
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characteristic or trait. Among them, the identity centralities associated with gender and
race constitute visible identities and can be molded to improve outcome variables such as
treatment adherence, coping mechanisms, and resilience (Jamil, Harper, & Fernandez,
2009; Phinney & Chavira, 1992). Gender and race identities are associated with
biological and developmental processes and constitutes stronger identities with beneficial
roles. Many studies have also shown that harnessing such visible central identities
improved mental health outcomes in PLWH (Mossakowski, 2003; Earnshaw, 2015).
However, belonging to the HIV community does not generate a visible central identity as
observed in gender and race, but instead produces a concealable stigmatized identity
(CSI) (Quinn et al., 2014). Some studies have demonstrated that CSI is associated with
higher levels of distress and discomfort (Quinn & Chaudoir, 2009). The effects of HIV
identity as a CSI are questionable due to extremely sparse research on this topic.
Irrespectively, Harper and colleagues (2013) have proposed that a salient or centralized
HIV identity may be associated with detrimental effects such as poor treatment
adherence. They propose that when PLWH strongly identify with their HIV status, they
become overwhelmed and experience a range of negative emotions that adversely affect
treatment adherence (Harper et al., 2013). Due to the lack of rigorous and conclusive
studies on identity centrality in HIV, conclusions regarding its effects on PLWH are
questionable. Nevertheless, it is an important factor because development of an HIV
identity impacts the salience of other identities and has far reaching implications on the
overall process of making sense of the challenging experience and developing adaptive
coping strategies (Baumgartner & Niemi, 2013).
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Summary
The subsections of this review (HIV stigma, treatment adherence, social support,
coping, depression and anxiety) represent a broad range of significant issues in the
current field of HIV research. While there is substantial evidence to the hypotheses
explored in this dissertation, contradictions exist in a number of key areas. In regards to
the association between HIV and depressive disorders, for example, a majority of the
studies demonstrated a clear relationship, and yet some studies report that HIV status was
not associated with depression (Kelly et al., 1998; Rabkin, et al., 1997). Similarly, in
regards to stigma and mental health, some studies have challenged the mediating role of
social support in the relationship between HIV-related stigma and mental health (Breet,
Kagee, & Seedat, 2014). The relationship between internalized HIV stigma and
medication adherence ranges from inversely strong (Rao et al., 2012; Sayles et al., 2007)
to weak or no associations (Kalichman et al., 2008). The diversity in the strength of
association between different outcome variables observed in different studies as well as
the approaches, methodologies, and sampling contexts used across the literature suggest
the need for further investigations. These investigations should be directed towards the
intersections and interactions of multiple, simultaneously active components of HIV
stigma, treatment adherence, social support, coping, depression and anxiety and their
collective role in HIV care and well-being.
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CHAPTER III: Relationship between HIV-Related Stigma and Treatment
Adherence and the Mediating Effects of Coping Strategies in Alcohol Using PLWH
in Haiti
Introduction
Advancements in HIV-related treatment and care have significantly improved and
extended the lives of people living with HIV (PLWH) (Bor, Herbst, Newell, &
Bärnighausen, 2013). Despite these medical advances, progress in the social sphere has
been very limited. Stigma, the social phenomenon involving labeling, stereotyping, and
discrimination has been identified as one of the primary barriers to the provision of
adequate care and support for PLWH (Morris et al., 2014)
The social stigma associated with HIV continues to exact devastating
consequences on its victims (Tsai, 2013). Research shows that HIV-related stigma is far
more intense when compared to the stigmas associated with other illnesses such as
herpes, cancer, tuberculosis etc. (Earnshaw & Kalichman, 2013). HIV-related stigma has
significant effects not only on the diagnosed individuals, but also their family members,
their health workers and volunteers (Ha, Chuc, Hien, Larsson, & Pharris, 2013; Bogart et
al., 2008). HIV-related stigma has been associated with broader social inequalities,
becoming further entrenched by the compounded layering of existing stigmas related to
drug use, and homosexuality (Reidpath & Chan, 2005; Takács, Kelly, P Tóth, Mocsonaki
& Amirkhanian, 2013; Rudolph et al., 2012; Onyebuchi-Iwudibia & Brown, 2014). HIVrelated stigma experiences are consistently associated with poor mental and physical
health outcomes - including anxiety and depression, increased risky sexual behaviors,
lower self-esteem, lower CD4 counts and higher levels of viral load (Bunn, Solomon,
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Miller, & Forehand, 2007; Storholm et al., 2013; Earnshaw, Smith, Chaudoir, Amico, &
Copenhaver, 2013; Holzemer et al., 2007; Preston, D'Augelli, Kassab, & Starks, 2007).
Though many distinct forms of HIV-related stigma have been identified, perceived
stigma has been associated with significant adverse effects in PLWH (Earnshaw &
Chaudoir, 2009). Those experiencing higher levels of perceived stigma are at increased
risk of transmitting their infection to others, and display elevated levels of depression,
anxiety, and helplessness (Lee, Kochman, Sikkema, 2002; Earnshaw, Bogart, Dovidio &
Williams, 2013).
Given the well documented negative effects of stigma experiences among PLWH,
coping mechanisms have become a focus of substantial research. Coping has been
defined as ongoing behavioral and cognitive efforts to manage and overcome taxing
demands connected to stressful, painful, and difficult situations (Chida & Vedhara,
2007). Coping has been conceptualized as a crucial process mediating the antecedent and
subsequent outcomes of psychological stress. While multiple categories of coping
strategies have been identified, the two most common groupings are adaptive coping
(directly engaging with situations via problem-solving, information seeking, cognitive
restructuring, etc.) and maladaptive coping (engaging in denial and avoidance; Kotzé,
Visser, Makin, Sikkema & Forsyth, 2013). Studies consistently show that adaptive
coping strategies result in more positive outcomes, including higher quality of life, selfesteem, decreased psychological distress, lower frequency of substance use, and greater
treatment adherence (Vervoort et al., 2009; Vyavaharkar et al., 2011; Trevino et al.,
2010; Kraaij et al., 2008; Pence et al., 2008). In contrast, maladaptive coping leads to
poor quality of life, higher anxiety, decreased physical functioning, and greater
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psychological distress (Kraaij et al., 2008; Brook & Willoughby, 2016; Ferreira-Valente,
Pais-Ribeiro & Jensen, 2014; Joyce et al., 2015). Maladaptive coping also predicts faster
disease progression and could affect mortality (McIntosh et al., 2015).
The relationship between HIV related stigma, coping and treatment adherence is
extremely relevant because many studies have recommended moderate to high levels of
treatment adherence in order to ensure adequate control over the disease (Kobin & Sheth,
2011; Parienti et al., 2008; Shuter, Sarlo, Kanmaz, Rode & Zingman, 2007). Treatment
non-adherence can result in uncontrolled viral load, (increasing the risk of sexual
transmission), non-recuperating CD4 counts (faster progression to AIDS), and significant
drug resistant viral strains (Weiser, Palar, Frongillo, Tsai & Kumbakumba, 2014;
Nachega et al., 2011). Therefore, understanding the factors affecting treatment adherence
is crucial. Treatment adherence is influenced by a range of psycho-social factors. Some
of the factors influencing HIV treatment adherence include: memory; adverse effects of
medications; regimen complexity; domestic responsibilities; availability and access to
medications; existing comorbidities; psychiatric problems such as depression and
anxiety; and subjective knowledge and awareness about the disease (Kardas, Lewek &
Matyjaszczyk, 2013). Stigma and coping mechanisms are important psycho-social factors
affecting treatment adherence in PLWH (Lyimo et al., 2014). In a study by Rintamaki
and colleagues (2006), it was observed that participants experiencing higher levels of
stigma were 3.3 times more likely to report sub-optimal treatment adherence. Similarly, a
meta-analysis done by Katz et al. (2013), reports that stigma undermines social support
and adaptive coping and thus compromises treatment adherence among PLWH. Thus,
stress, social isolation, and diminished view of self that result from perceived stigma have
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many negative repercussions when it comes to adhering to prescribed medical treatment
for HIV. Furthermore, coping mechanisms have the potentials to alleviate many of these
repercussions. Clearly, HIV-related stigma, coping strategies, and adherence intersect in
complex and mutually consequential ways. This study, therefore, aims to clarify the
relationships among these factors by exploring their effects within HIV positive alcohol
users living in Haiti. The study also examined the association between health care
satisfaction and treatment adherence, which is an important individual-level factor in the
clinical setting which could affect treatment adherence.
Methods
Study Design and Population
The current study utilized a secondary analysis of data from the parent study
titled, “Intervening with Haitian HIV positive Alcohol Users: An Environmental
Psychosocial Framework.” The parent study was a randomized controlled trial that
examined the effectiveness of the adapted CBSM-A intervention in simultaneously
reducing risk behaviors, improving ART adherence and mood. Participants were
provided information on HIV disease and its treatment, including currently available
ART medications, the negative effects of substance use and high-risk sexual behavior on
the immune system and health status, and the nature of stress, coping responses and
resources. The skill building aspects of the parent study included: teaching anxiety
reduction skills such as progressive muscle relaxation, relaxing imagery and autogenics;
modifying maladaptive cognitive appraisals using cognitive restructuring; enhancing
interpersonal conflict resolution skills and anger expression via anger management and
assertion training; and providing a supportive group environment and increasing
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utilization of social support networks. Data collection for the parent study occurred at the
GHESKIO (Groupe Haitien d’Etude du Sarcome de Kaposi et des Infections
Opportunistes) Centers in Port-au-Prince, Haiti. The CBSM-A intervention was designed
to include a combination of problem-focused (e.g., active coping and planning) and
emotion-focused (e.g., relaxation training, seeking emotional support) coping strategies.
The parent study included participants who were: between 18 and 60 years of age;
fluent in spoken Haitian Creole; documented HIV seropositivity; reported at least one
episode of unprotected anal or vaginal sex in the past 90 days; reported recent alcohol
consumption; were not cognitively impaired at the time of recruitment; and did not show
symptoms of any major psychiatric disorder. The current study included subjects who
participated in baseline assessments before the beginning of randomization and
intervention. The institutional review board (IRB) at Florida International University
approved this secondary analysis study in September, 2015.
Measures
HIV Treatment Adherence
HIV treatment adherence was measured using the Community Programs for
Clinical Research on AIDS (CPCRA) Antiretroviral Medication Self-Report
questionnaire (Form 646; Terry Beirn Community Programs for Clinical Research on
AIDS, 2003; see Appendix II). This questionnaire uses a global 7-day recall and has slots
for recording drug name, drug code, number of pills per dose, number of doses per day,
and total number of pills per day. For each of the prescribed medications, the
questionnaire records whether the patients took “all,” “most,” “about half,” “very few,”
or “none” of their pills during the preceding seven days. Adherence to each medication is
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calculated based on the percentages assigned to each of these responses, which include:
“all” (100%); “most” (80%); “about half” (50%); “few” (20%); and “none” (0%). Total
adherence is calculated as the mean of the total scores of all the individual medications
and constitutes a continuous variable ranging from 0-100 percent. In this study,
participants were categorized into those who reported ≥95% adherence to all medications
(high treatment adherence) and those who reported <95% treatment adherence (low
treatment adherence). Previous studies have reported ≥95 % adherence rates as ideal
treatment adherence (Mannheimer et al., 2006).
The questionnaire also includes a checklist of ten possible reasons why the
antiretroviral doses were missed, which include: side effects; pill burden; forgetfulness;
being away from home; concerns about confidentiality; difficulties with dietary
requirements; and confusion. However, these questions could be asked to only those
participants who reported missed medications. Therefore, in this study, descriptive
statistics were used to understand the reasons for non-adherence.
Stigma of HIV/AIDS
HIV/AIDS related stigma was measured using the Perceived Stigma of
HIV/AIDS scale (Bauman, Camacho, Westbrook, & Forbes-Jones, 1997; Bauman,
Silver, & Camacho, 2000; Westbrook & Bauman, 1996; see Appendix I). This scale
measures stigma in terms of two components – internalized stigma and externalized
stigma. In order to measure these two parameters, the questionnaire includes two
subsections – personal view and public view. The personal view subscale includes
questions related to shame, guilt, blame, embarrassment, and poor self-worth due to HIV.
The public view subscale includes questions related to participant’s perception about
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social stigma, for example, what the respondent thinks about other people's attitudes and
beliefs towards his/her disease condition. The questions in the subscales are both
positively and negatively phrased to increase the specificity of the responses. Both
subscales have 24 questions measured on a four-point Likert-type scale (1 = strongly
agree to 4 = strongly disagree). The total score of each subscale ranges between 24 and
96 and higher scores represent higher levels of stigma. Cronbach’s alpha of the
instrument was 0.869.
Coping
Coping strategies were measured using the Brief COPE questionnaire (Carver,
1997; see Appendix IV). The Brief COPE questionnaire includes 28 questions classified
into 14 components with two questions per component. Each question is measured using
a 4-point scale (1 = I have not been doing this at all; 2 = I've been doing this a little bit; 3
= I've been doing this a medium amount; and 4 = I have been doing this a lot). The 14
components include: self-distraction, active coping, denial, substance use, use of
emotional support, use of instrumental support, behavioral disengagement, venting,
positive reframing, planning, humor, acceptance, religion, and self- blame. Based on
evidence that these factors tend to be either generally adaptive or problematic, the 14
components are further classified into two domains: adaptive coping or maladaptive
coping (Carver, 1997). The adaptive coping domain contains eight components with
possible scores of 0 to 48, and higher scores signify greater levels of adaptive coping.
This domain includes the following components: active coping, planning, positive
reframing, acceptance, humor, religion, using emotional support, and using instrumental
support. The maladaptive coping domain contains six components with possible scores of
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0 to 36, and higher scores signify greater levels of maladaptive coping. This domain
includes the following components: self-distraction; denial; venting; substance use;
behavioral disengagement; and self-blame. Cronbach’s alpha of the instrument was
0.907.
Satisfaction with the Quality of Care
Satisfaction with quality of care received by the participants was assessed by
asking, “How satisfied were you with the quality of care you received at the visit?” and
measured using a 4-point scale (1 = very satisfied; 2 = satisfied; 3 = unsatisfied; and 4 =
very unsatisfied).
Data Analyses
IBM SPSS Statistics (Version 23) and IBM SPSS Analysis of Moment Structures
(AMOS; Version 23) were used for data analysis (Armonk, NY: IBM Corp.).
Frequencies, means, standard deviations, t tests, chi-square tests and Fisher's exact tests
were used to describe the demographic characteristics. Independent samples t tests were
used to compare perceived stigma and coping variables between those reporting low
versus high treatment adherence. In addition, the reasons for non-adherence to
medications were described using percentages among participants with less than
complete (<100%) treatment adherence. Pearson correlations were used to find
associations between treatment adherence, and the domains of perceived stigma (personal
view and public view), coping variables (adaptive coping and maladaptive coping), and
satisfaction with quality of care scores. Multivariable linear regressions were used to
estimate the predictors of treatment adherence with demographics, stigma and coping
domains and satisfaction with quality of care scores as independent variables. In the
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regressions analysis, crude models were used initially and subsequently adjusted for
associated covariates. The covariates were also tested for significant associations with the
outcome variable using bivariate analysis before being incorporated into the final model.
To increase the validity of the model, multicollinearity among covariates was tested prior
to regression analyses. Adjusted models included non-missing values for all independent
variables included in the models. Structural equation modeling (SEM) was used to test
the hypothesis of whether the relationship between stigma and HIV treatment adherence
variables were mediated by coping variables. SEM accounts for multiple interactive
relationships and variances and explores for directional associations between them
leading to delineation of the mediators (Grimm & Yarnold, 2000; Kline, 1998). In the
analysis, maximum-likelihood estimation was used for the AMOS modules. Statistical
significance was set at p <0.05 for all the analyses.
Results
Demographic and socio-economic characteristics
A total of 285 participants who reported taking medications were included in the
secondary analyses and 122 (42.8%) were men (Table 1). The mean age of the cohort
was 36.43±8.62 (Mean±SD) years. About 59% of the participants had a 6th grade or less
education. Approximately 60% reported that they were married and about 59.2% were
unemployed. The majority of the participants reported having primary care physicians
(91.2%).
Stigma and HIV treatment adherence
Participants with higher HIV treatment adherence reported significantly lower
levels of perceived stigma scores (p = .049; Table 2). However, there were no significant
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differences between low versus high treatment adherence with respect to perceived
stigma-personal view and perceived stigma-public view. Satisfaction with quality of care
scores were significantly greater in those reporting high adherence to treatment. There
was also significant difference in age, educational levels and marital status between those
reporting low versus high treatment adherence.
Coping scores and HIV treatment adherence
There were no significant differences in total coping scores between participants
reporting higher versus lower treatment adherence (Table 3). However, with respect to
total maladaptive coping scores, participants reporting low treatment adherence scored
significantly higher than participants reporting high treatment adherence (p = .021).
Similarly, with respect to the individual components of maladaptive coping, substance
use (p = .018) and behavioral disengagement (p = .011), the low treatment adherence
group scored significantly higher. However, with respect to the individual components of
adaptive coping, use of instrumental support (p = .047), the high treatment adherence
group scored significantly higher.
Reason for not taking medication
A significant number of participants (48.8%) reported problems taking pills at
specified times (Table 4). This was followed by forgetting to take the pills (42.5%) and
not wanting others to notice taking medications (38.8%).
Relationship between adherence, perceived stigma, coping and satisfaction
Significant negative correlations were observed between treatment adherence, and
total perceived stigma (r = -.119, p <0.05), and maladaptive coping domain of coping
strategies (r = -.129, p <0.05). Irrespective of the associations between treatment
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adherence and total perceived stigma, the individual domains of perceived stigma –
personal view and public view – did not show any association with treatment adherence.
Total coping scores also did not show any significant association with treatment
adherence. Significant positive correlations were observed between treatment adherence
and satisfaction with quality of care scores (r = .157, p <0.01; Table 4).
Predictors of HIV treatment adherence
In the adjusted multivariable linear regression model perceived stigma (Beta = .049, p = .031), showed significant negative associations with treatment adherence,
whereas, satisfaction with quality of care scores (Beta = .032, p = .041) showed positive
association with treatment adherence. However, there were no associations between
maladaptive coping and treatment adherence.
Mediation analysis
In the mediation analysis, coefficients were simultaneously estimated for all the
variables that showed significant associations in bivariate analyses including treatment
adherence, perceived stigma and maladaptive coping. However, there were no significant
association between these variables in the mediator analyses. Figure 1 shows the path
diagram for these variables. In this model, there were significant negative associations
between perceived stigma and treatment adherence (Beta = -.208, p = .016) and
maladaptive coping and treatment adherence (Beta = -.180, p = .037). However, there
were no associations between perceived stigma and maladaptive coping (Beta = .029, p =
.740). These observations suggest that the effect of stigma on HIV treatment adherence is
not mediated by maladaptive coping.

69

Discussion
Results of this study show that perceived stigma and quality of care satisfaction
scores were significant predictors of HIV treatment adherence among alcohol using
PLWH in Haiti. Mediation analyses, however, showed that maladaptive coping did not
act as a mediator between perceived stigma and treatment adherence. This could be due
to the stronger effects of perceived stigma on treatment adherence.
The mean adherence in this study was 93.1%, and this included 100% adherence
reported by 71.9% of the cohort. About 72.3% of the participants reported ≥95%
adherence. This is comparable to many other studies done among PLWH in similar
resource limited settings. For example, in a Ugandan study done by Byakika-Tusiime and
colleagues (2005), > 95% adherence was reported by 68% of the participants. Likewise, a
study in Senegal reported 91% adherence for all participants (Lanièce et al., 2003).
Achieving higher levels of adherence to a remarkably complex regimen is not only
challenging but also demanding for both patients and caregivers (Johnson, Heckman,
Hansen, Kochman & Sikkema, 2009; Murphy, Roberts, Martin, Marelich & Hoffman,
2000). Despite meticulous efforts by healthcare professionals, PLWH continue to miss
doses, misinterpret medication schedules and misrepresent adherence levels (Gust et al.,
2011). The high levels of adherence observed in this study could be attributed to the
meticulous efforts done by the staff at the GHESKIO centers in Haiti.
The finding that treatment adherence was inversely associated with perceived
stigma scores is consistent with many other studies done in other PLWH populations. For
example, in a cross-sectional study of 204 American PLWH, adherence measured
through Patient Medication Adherence Questionnaire (PMAQ) was inversely associated
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with internalized stigma and disclosures of HIV status (Waite, Paasche-Orlow,
Rintamaki, Davis & Wolf, 2008) Similarly, in a South African study, adherence
measured through ACTG Adherence Instrument was adversely associated with fear of
stigma (Spire et al., 2002). In this study, though the total perceived stigma scores showed
significant negative associations with treatment adherence, there were no associations
between the two domains of total perceived stigma – personal view and public view –
and treatment adherence.
In this study, maladaptive coping was not associated with treatment adherence.
However, in a previous study done in the same population, Malow et al. (2013), reported
that maladaptive coping indirectly affected treatment adherence through mediating
variables such as greater depression and negative attitudes about medications. However,
in the current study we did not measure depression and negative attitudes about
medications, thereby limiting the conclusions of this study. Irrespective of these findings,
a number of studies reported that maladaptive coping was associated with adverse
outcomes in HIV including treatment adherence. In a study by McIntosh et al. (2015),
maladaptive coping was associated with higher rates of disease progression and faster
occurrence of AIDS symptoms. Maladaptive coping was also associated with increased
sexual risk behaviors which could lead to higher disease transmission rates (Sánchez,
Rice, Stein, Milburn & Rotheram-Borus, 2010). In a study by Johnson and colleagues
(2009), maladaptive coping had significant adverse effects on social support variables
such as social well-being, and support from family/friends which contributed to negative
effects such as depression, anxiety and lower psychological well-being scores, which in
turn indirectly affected adherence to ART.
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In the current study, there were positive associations between quality of care
satisfaction scores and treatment adherence. Similarly, in a study done by Martinez et al.
(2012), health care satisfaction significantly moderated (alleviated) the adverse effects of
stigma on treatment adherence and the effects strengthened over time. Many other studies
have demonstrated the beneficial effects of health care satisfaction on treatment
adherence (Bennett, Fuertes, Keitel & Phillips, 2011; Martinez et al., 2012; Barbosa,
Balp, Kulich, Germain & Rofail, 2012). Satisfaction with heath care is associated with
trusting, positive, and working relationships between patients and health care providers
including availability during times of urgency, needs and illness (Urowitz & Deber,
2008). Some of the factors associated with improved health care satisfaction scores
include comprehensiveness, competence, continuity of care, consistency, and compassion
demonstrated by the health care personnel during clinical encounters (Williams &
Friedland, 1997).
In this study, the two most common reasons for non-adherence included inability
to comply with complex medication schedules and forgetfulness. Both of these reasons
have been identified as common causes for nonadherence in many studies (Adefolalu &
Nkosi, 2013; Byakika-Tusiime et al., 2005). Some of the reasons for forgetting their
medications include frequent residential changes, changes in living patterns, or travelling
for a living (Vervloet, 2012). Some studies have suggested the beneficial effects of
adherence counseling in providing assistance to PLWH in terms of follow-up visit
reminders, treatment diaries, pill boxes and alarmed pill bottles. For example, in a study
among female PLWH in Kenya, adherence significantly improved with such efforts
(Frick, Lavreys, Mandaliya & Kreiss, 2001).
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There were some limitations to this study. The study participants were recruited
from the GHESKIO centers, which provide comprehensive health care services, free of
charge, to socioeconomically underprivileged communities in Haiti. Participants in this
study could have differed significantly from PLWH who have limited access to the
GHESKO centers due to several structural barriers. Thus, the results of this study cannot
be generalized to the entire population of PLWH from Haiti. The current study was a
secondary analysis of baseline data collected for the parent study. This could have caused
some surrogate information biases in the current study. The data is self-reported, and
participants were HIV positive alcohol users, which may increase recall bias and social
desirability biases could have affected the findings of this study. Because of the crosssectional nature of the study, causal associations could not be determined and because of
lack of HIV-negative comparison group the effects of other confounders could not be
eliminated.
Conclusion
PLWH experience considerable levels of internalized and externalized stigma to
which they react using coping strategies. In this cross-sectional study of HIV positive
alcohol users in Haiti, we found that perceived stigma was adversely associated with
treatment adherence, whereas health care satisfaction was positively associated with
treatment adherence. These findings suggest that adherence enhancing interventions
should consider HIV-related stigma and health care satisfaction levels. Additional factors
such as difficulty following complicated schedules, forgetfulness and confidentiality for
medications should be addressed in such interventions.
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Table 3.1. Demographic characteristics of the participants
Characteristics
HIV treatment adherence p value
Total
(n=285,
Low
High
100%)
(n=79,
(n=206,
27.7%)
72.3%)
Age*
34.46±8.05
37.23±8.75
.015
36.43±8.62
Gender
.307
Male
30 (38.0%)
92 (44.7%)
122 (42.8%)
Female
49 (62.0%)
114 (55.3%)
163 (57.2%)
Education*
.022
6th grade or less
36 (48.0%)
127 (63.2%)
163 (59.1%)
Some high school or
39 (62.0%)
74 (36.8%)
113 (40.9%)
higher
Marital status**
.009
Single or living as
41 (51.9%)
72 (35.0%)
113 (39.6%)
single
Married
38 (48.1%)
134 (65.0%)
172 (60.4%)
Employment
.286
Full time job
1 (2.0%)
4 (3.7%)
5 (3.2%)
Seasonal job
11 (22.4%)
27 (25.0%)
38 (24.2%)
Unemployed
28 (57.1%)
65 (60.2%)
93 (59.2%)
Student
3 (6.1%)
1 (0.9%)
4 (2.5%)
Incapacitated
1 (2.0%)
0 (0%)
1 (0.6%)
Other
5 (10.2%)
11 (10.2%)
16 (10.2%)
Income
.857
<$150
9 (30.0%)
25 (26.0%)
34 (27.0%)
$151-1,000
10 (33.3%)
37 (38.5%)
47 (37.3%)
>$1,000
11 (36.7%)
34 (35.4%)
45 (35.7%)
Primary care
.151
Yes
69 (87.3%)
191 (92.7%)
260 (91.2%)
No
10 (12.7%)
15 (7.3%)
25 (8.8%)
Satisfaction with quality 3.12±0.89
3.36±0.04
.016
3.29±0.73
of care*
Note: P value corresponds to independent samples t test, chi-square test or Fisher's exact
test
*p<.05; **p<.01; ***p<.001
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Table 3.2. Participants’ stigma by level of HIV treatment adherence
Stigma
HIV treatment adherence
p value
Total
Low
High
Personal
54.82±7.96
54.48±8.25
.752
54.57±8.13
Public
54.75±9.29
54.02±10.62 .592
54.15±10.30
Total
109.58±14.64 108.24±17.55 .049
108.54±16.79
*p<.05; **p<.01; ***p<.001
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Table 3.3. Participants’ Brief COPE scores by level of HIV treatment adherence
Brief COPE
HIV treatment adherence p value
Total
Low
High
Adaptive coping
Positive reframing
5.06±1.79
5.00±1.76
.815
5.02±1.77
Use of instrumental support* 4.75±1.64
5.21±1.95
.047
5.12±1.88
Religion
5.80±1.61
5.95±1.71
.502
5.94±1.68
Use of emotional support
4.92±1.80
4.87±1.73
.850
4.90±1.75
Acceptance
5.18±1.65
4.98±1.66
.375
5.03±1.65
Planning
5.44±1.52
5.32±1.67
.568
5.36±1.62
Active coping
5.36±1.73
5.08±1.81
.241
5.16±1.80
Humor
4.81±1.67
4.73±1.79
.742
4.77±1.76
41.35±8.82 41.18±9.31
.892
41.33±9.16
Total adaptive coping
Maladaptive coping
Self-distraction
Denial
Substance use*
Behavioral disengagement*
Venting
Self-blame
Total maladaptive coping*
Total coping
*p<.05; **p<.01; ***p<.001

5.23±1.78
5.17±1.60
5.13±2.25
5.92±1.90
5.15±1.76
5.23±1.78
32.26±7.25

4.78±1.73
4.92±1.84
4.44±2.09
5.24±1.95
5.05±1.80
4.78±1.73
29.78±8.21

73.61±14.76 70.97±15.80
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.054
.298
.018
.011
.668
.204
.021

5.02+1.78
4.98±1.79
4.65±2.15
4.92±1.74
5.07±1.77
5.39±1.94
30.44±7.99

.193

71.78±15.50

Table 3.4. Reasons for not taking medication by participants with low HIV treatment
adherence
Reason
n (%)
I feel worse when I take the pills
17 (21.3%)
There are too many pills to take
15 (18.8%)
I forget to take the pills
34 (42.5%)
I ran out of pills
4 (5.0%)
I don't think I need the pills
14 (17.5%)
I was away from home
25 (31.3%)
I did not want others to notice
31 (38.8%)
I am too busy
18 (22.5%)
I had problems taking pills at specified times (with
39 (48.8%)
meals, on empty stomach, etc.)
I was confused or uncertain about how to take the pills 10 (12.5%)
*p<.05; **p<.01; ***p<.001
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Table 3.5. Correlation between adherence, perceived stigma, coping and satisfaction
1
2
3
4
5
6
7
1. Adherence
--2. Personal view
-.042
--3. Public view
-.106
.313** --4. Perceived stigma
-.119* .612** .703**
--5. Adaptive coping
-.025
-.227** -.182** -.222** --6. Maladaptive coping -.129* -.077
-.071
-.066
.632** --7. Total coping
-.081
-.174** -.144*
-.165** .917** .889** --8. Satisfaction
.157** -.081
-.049
-.025
-.003
-.084
-.045
*p<.05; **p<.01; ***p<.001
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---

Table 3.6. Multivariable linear regression predicting depression
Independent variables
Estimate
Standard
Beta
error
Age
0.002
0.001
0.082
Sex
-0.007
0.024
-0.02
Education
-0.038
0.017
-0.142
Marital status
0.044
0.023
0.113
Satisfaction*
0.032
0.016
0.123
Maladaptive coping
-0.002
0.001
-0.091
Stigma*
-0.049
0.023
-0.131
*p<.05; **p<.01; ***p<.001
Adjusted R-squared value = .24
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p value
0.184
0.753
0.921
0.061
0.041
0.133
0.031

Figure 3.1. Path diagram to describe the interrelationship between HIV related stigma,
coping and HIV treatment adherence

Maladaptive
Coping
.03

Perceived stigma

-.18*
-.21*

Adherence

*p<.05; **p<.01; ***p<.001
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CHAPTER IV: Effects of Stigma and Anxiety on Treatment Adherence with
Maladaptive Coping as Mediator among HIV-Positive Alcohol Users in Haiti
Introduction
HIV is a global health problem, and despite significant advancements in treatment
and prevention strategies, it remains one of the most stigmatized diseases worldwide.
Among PLWH, stigma contributes to considerable emotional and psychological distress
(Stutterheim et al., 2011) and acts as one of the greatest barriers to adequate treatment
and control (Katz, et al., 2013). As a social and structural phenomenon involving
stereotyping, status loss, and discrimination, stigma represents a significant risk factor for
mental health problems among PLWH (Mahajan et al., 2008; Earnshaw & Chaudoir,
2009). HIV-related stigma has been consistently associated with increased anxiety,
depression, PTSD, alcoholism, drug use and other psychiatric disorders (Dévieux et al.,
2013; Kamen et al., 2015; Yi et al., 2015).
There are several studies which show that PLWH experience greater levels of
dysfunctional personality and negative affective disorders (Olley, et al., 2015; Houston,
Sandfort, Watson, & Caton, 2013). There are three streams of empirical evidence that
associate HIV/AIDS with affective disorders. The first stream of evidence consists of
studies that demonstrate remarkably higher levels of stress in PLWH (McIntosh &
Rosselli, 2012; Kalichman & Grebler, 2010). These stressors are associated with
physical, social, and medical aspects of the disease itself (Orban et al., 2010). The second
stream of evidence comes from studies which show that PLWH additionally experience
higher levels of life stressors not directly related to the disease. For example, abuse
history, domestic violence, and poor socioeconomic status (Jewkes, Dunkle, Nduna &
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Shai, 2010). The third stream of evidence comes from studies which show that PLWH
inherently have increased susceptibility to psychiatric disorders due to unknown factors
when compared to HIV-negative individuals within the same populations (Mayston,
Kinyanda, Chishinga, Prince & Patel, 2012). Though the associations between HIV and
anxiety have been relatively less documented when compared to other psychiatric
disorders, a few studies have shown significant associations between HIV infection and
post-traumatic stress disorders, generalized anxiety disorders, and panic disorders
(Vranceanu et al., 2008; Myer et al., 2008). This evidence shows that there is a greater
need to address anxiety disorders especially in a resource-limited nation like Haiti.
Coping is defined as efforts to deal with demands taxing or exceeding the
resources of the person (Lazarus & Folkman, 1984). Coping includes constant behavioral
and cognitive efforts to manage and overcome the stressful demands connected to
traumatic, painful, or difficult situations (Chida & Vedhara, 2007). Ever since the
emergence of the epidemic, a number of studies have documented the beneficial effects
of coping on stress and illness (McIntosh & Rosselli, 2012). Folkman (1997)
demonstrated that coping mechanisms were associated with positive mind states in
PLWH. Though several types of coping have been identified in the literature, two forms
predominate – adaptive coping and maladaptive coping. Adaptive coping includes direct
engagement strategies such as problem-solving, information seeking, and cognitive
restructuring, whereas maladaptive coping includes patterns of denial and avoidance
(Kotzé, et al., 2013). Adaptive coping is a resilient strategy because it involves positive
means of adaptation and enables beneficial recovery and recuperation (Sinclair &
Wallston, 2004). Research in this area also concludes that the meaning ascribed to HIV
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varies between individuals and so various coping strategies may be differentially
effective. Thus, coping interventions for PLWH may be most effective when tailored to
individual life contexts and appraisals of PLWH with respect to their disease (Moskowitz
& Wrubel, 2005).
Many studies have recommended moderate to high levels of treatment adherence
in order to ensure adequate control over the disease (Kobin & Sheth, 2011; Parienti et al.,
2008; Shuter et al., 2007). Treatment non-adherence can result in uncontrolled viral load,
(increasing the risk of sexual transmission), non-recuperating CD4 counts (faster
progression to AIDS), and significant drug resistant viral strains (Weiser, Palar,
Frongillo, Tsai & Kumbakumba, 2014; Nachega et al., 2011). Therefore, understanding
the factors affecting treatment adherence is crucial. A number of studies have shown
adverse associations between anxiety disorders and treatment adherence in PLWH
(Springer, Dushaj & Azar, 2012). Given the consequential effects of stigma and coping
mechanisms on anxiety disorders and their combined effects on treatment adherence, the
current study aims to explore these associations in a sample of HIV positive alcohol users
in Haiti.
Methods
Study Design and Population
The current study was a secondary analysis of data from the parent study titled,
“Intervening with Haitian HIV positive Alcohol Users: An Environmental Psychosocial
Framework.” The parent study was a randomized controlled trial that examined the
effectiveness of the adapted CBSM-A intervention in simultaneously reducing risk
behaviors, improving ART adherence, and mood. Participants were provided
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information on HIV disease and its treatment, including currently available ART
medications, the negative effects of substance use and high-risk sexual behavior on the
immune system and health status, and the nature of stress and coping responses and
resources. The skill building aspects of the parent study included: teaching anxiety
reduction skills such as progressive muscle relaxation, relaxing imagery and autogenics;
modifying maladaptive cognitive appraisals using cognitive restructuring; enhancing
interpersonal conflict resolution skills and anger expression via anger management and
assertion training; and providing a supportive group environment and increase utilization
of social support networks. Data collection for the parent study occurred at the
GHESKIO (Groupe Haitien d’Etude du Sarcome de Kaposi et des Infections
Opportunistes) Centers in Port-au-Prince, Haiti. The CBSM-A intervention was designed
to include a combination of problem-focused (e.g., active coping and planning) and
emotion-focused (e.g., relaxation training, seeking emotional support) coping strategies.
The parent study included participants who were: between 18 and 60 years of age;
fluent in spoken Haitian Creole; documented HIV seropositivity; reported at least one
episode of unprotected anal or vaginal sex in the past 90 days; reported recent alcohol
consumption; were not cognitively impaired at the time of recruitment; and did not show
symptoms of any major psychiatric disorder. The current study included subjects who
participated in baseline assessments before the beginning of randomization and the
interventional The institutional review board (IRB) at Florida International University
approved this secondary data analysis study in September, 2015.
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Measures
State Anxiety
State anxiety was assessed using the State-Trait Anxiety Inventory (STAI), Form
Y-1 (Spielberger, Gorsuch & Lushen, 1970; see Appendix V). STAI has two sections –
Form Y-1 and Form Y-2. The first section of the inventory (Form Y-1) includes 20
questions which measure transitory state anxiety levels in terms of a 4-point Likert scale
(1 = not at all; 2 = somewhat; 3 = moderately so; and 4 = very much so). The total state
anxiety scores are obtained by adding the scores for each of the 20 questions and range
between 20 and 80. Higher scores signify greater levels of state anxiety. A cutting point
of 39-40 has been suggested to indicate clinically significant symptoms for the state
anxiety scale (Knight et al., 1983; Addolorato et al., 1999). The second section of the
inventory (Form Y-2) also includes 20 questions which measure long term trait anxiety.
However, trait anxiety levels change over extremely long periods of time and cannot be
used for relatively short studies (Julian, 2011). The parent study did not measure trait
anxiety levels due to the same reason. Cronbach’s alpha of the instrument was 0.744.
Stigma of HIV/AIDS
HIV/AIDS related stigma was measured using the Perceived Stigma of
HIV/AIDS scale (Bauman, Camacho, Westbrook, & Forbes-Jones, 1997; Bauman,
Silver, & Camacho, 2000; Westbrook & Bauman, 1996; see Appendix I). This scale
measures stigma in terms of two components – internalized stigma (personal view) and
externalized stigma (public view). In order to measure these two parameters, the
questionnaire includes two subsections – personal view and public view. The personal
view subscale includes questions related to shame, guilt, blame, embarrassment, and poor
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self-worth due to HIV. The public view subscale includes questions related to
participant’s perception about social stigma, for example, what the respondent thinks
about other people's attitudes and beliefs towards his/her disease condition. The questions
in the subscales are both positively and negatively phrased to increase the specificity of
the responses. Both subscales have 24 questions measured by four-point Likert-type scale
(1 = strongly agree to 4 = strongly disagree). The total score of each subscale ranges
between 24 and 96 and higher scores represent higher levels of stigma. Cronbach’s alpha
of the instrument was 0.869.
Coping
Coping strategies were measured using the Brief COPE questionnaire (Carver,
1997; see Appendix IV). The Brief COPE questionnaire includes 28 questions classified
into 14 components with two questions per component. Each question is measured using
a 4-point scale (1 = I have not been doing this at all; 2 = I've been doing this a little bit; 3
= I've been doing this a medium amount; and 4 = I have been doing this a lot). The 14
components include: self-distraction, active coping, denial, substance use, use of
emotional support, use of instrumental support, behavioral disengagement, venting,
positive reframing, planning, humor, acceptance, religion, and self- blame. Based on
evidence that these factors tend to be either generally adaptive or problematic, the 14
components are further classified into two domains: adaptive coping or maladaptive
coping (Carver, 1997). The adaptive coping domain contains eight components with
possible scores of 0 to 48, and higher scores signify greater levels of adaptive coping.
This domain includes the following components: active coping, planning, positive
reframing, acceptance, humor, religion, using emotional support, and using instrumental
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support. The maladaptive coping domain contains six components with possible scores of
0 to 36, and higher scores signify greater levels of maladaptive coping. This domain
includes the following components: self-distraction; denial; venting; substance use;
behavioral disengagement; and self-blame. Cronbach’s alpha of the instrument was
0.907.
HIV Treatment Adherence
HIV treatment adherence was measured using the Community Programs for
Clinical Research on AIDS (CPCRA) Antiretroviral Medication Self-Report
questionnaire (Form 646; Terry Beirn Community Programs for Clinical Research on
AIDS, 2003; see Appendix II). This questionnaire uses a global 7-day recall and has slots
for recording drug name, drug code, number of pills per dose, number of doses per day,
and total number of pills per day (Appendix II). For each of the prescribed medications,
the questionnaire records, whether the patients took “all,” “most,” “about half,” “very
few,” or “none” of their pills during the preceding seven days. Adherence to each
medication is calculated based on the percentages assigned to each of these responses,
which include: “all” (100%); “most” (80%); “about half” (50%); “few” (20%); and
“none” (0%). Total adherence is calculated as the mean of the total scores of all the
individual medications and constitutes a continuous variable ranging from 0-100 percent.
In this study, adherence was considered as a continuous variable.
Data Analyses
IBM SPSS Statistics (Version 23) and IBM SPSS Analysis of Moment Structures
(AMOS; Version 23) were used for data analysis (Armonk, NY: IBM Corp.).
Frequencies, means, standard deviations, t tests, chi-square tests and Fisher's exact tests
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were used to describe the demographic characteristics. Independent samples t tests were
used to compare perceived stigma and coping variables between those reporting higher
versus lower levels of anxiety. Pearson correlations were used to find associations
between anxiety levels, treatment adherence, the domains of perceived stigma (personal
view and public view), and coping variables (adaptive coping and maladaptive coping).
Structural equation modeling (SEM) was used to test the hypothesis whether the
relationship between stigma and anxiety levels was mediated by the coping variable and
whether there were any combined effects on treatment adherence. SEM accounts for
multiple interactive relationships and variances and explores for directional associations
between them leading to delineation of the mediators (Grimm & Yarnold, 2000; Kline,
1998). For analysis, maximum-likelihood estimations were used for the AMOS modules.
Statistical significance was set at p <0.05 for all the analyses.
Results
Demographic and socio-economic characteristics
A total of 285 participants who reported taking medications were included in the
secondary analyses and 42.3% were men (Table 1). The mean age of the cohort was
36.43±8.62 (Mean±SD) years. About 59% of the participants had 6th grade or lesser
levels education. About 60% reported that they were married and 59.6% were
unemployed. The majority of the participants reported having primary care physicians
(90.2%). There were significant differences in age and gender between those reporting
low versus high levels of anxiety.
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Stigma and anxiety levels
There were no significant differences with respect to personal view, public view
as well as total perceived stigma between those reporting low versus high levels of
anxiety (Table 2).
Coping scores and anxiety levels
Participants who reported higher levels of anxiety also reported significantly
higher levels of total coping (p <.001; Table 3). Participants who reported higher levels of
anxiety reported higher levels of maladaptive coping (p <.001). However, there were no
significant differences in adaptive coping scores between participants reporting low
versus high levels of anxiety. Participants who reported higher levels of anxiety also
reported higher levels of planning, active coping, self-distraction, denial, substance use,
behavioral disengagement, venting, and self-blame components of the questionnaire
(Table 3).
Treatment adherence and anxiety levels
There were significant differences in treatment adherence between participants
reporting low versus high levels of anxiety. Participants who reported higher levels of
anxiety reported significantly lower levels of treatment adherence (p = .011; Table 4).
Relationship between anxiety, adherence, perceived stigma, and coping mechanisms
Significant negative correlations were observed between anxiety levels and
treatment adherence (r = -.141, p <0.05), and total coping scores (r = -.167, p <0.01;
Table 5). Significant positive correlations were observed between anxiety levels and total
perceived stigma (r = .123, p <0.05), perceived stigma-public view (r = .132, p <0.05)
and maladaptive coping (r = .398, p <0.01).
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Mediation analysis
In the mediation analysis, coefficients were simultaneously estimated for all the
variables that showed significant associations in bivariate analyses including perceived
stigma, maladaptive coping, anxiety levels, and treatment adherence. There were
significant associations between perceived sigma and maladaptive coping (Beta = .175, p
= .003), perceived sigma and anxiety (Beta = .164, p = .005), maladaptive coping and
anxiety (Beta = .229, p <.001), and anxiety and treatment adherence (Beta = -.140, p =
.018). Figure 1 shows the path diagram for these variables. These observations suggest
that maladaptive coping acted as a mediator on the relationship between stigma and
anxiety levels which in turn had significant effects on treatment adherence.
Discussion
Many studies have shown that stigma was associated with poor mental and
physical health outcomes, such as, anxiety and depression, increased risk seeking
behaviors, and adverse disease progression parameters such as lower CD4 counts and
higher viral load (Storholm et al., 2013; Earnshaw, Smith, Chaudoir, Amico, &
Copenhaver, 2013; Holzemer et al., 2007). In the present study, there were significant
associations between perceived stigma and anxiety levels. Results show that maladaptive
coping strategies significantly mediated the associations between stigma and anxiety
levels and in turn adversely affected treatment adherence.
PLWH experience varying levels of anxiety disorders as reported in associated
studies and range between 7% in some studies to as high as 82% in others (Kemppainen
et al., 2003; Morrison et al., 2011). In a study done among 1,125 PLWH in the
Southeastern United States, prevalence of anxiety disorders was as high as 39% (Pence,
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Miller, Whetten, Eron & Gaynes, 2006). Similarly, a survey done among 85 PLWH in
the South Africa showed that high levels of anxiety were reported by 52.9% of the
participants (Kagee & Martin, 2010). Akin to these findings, this study reported high
levels of anxiety in 47.2% of the participants.
In this study, maladaptive coping adversely mediated the effects of stigma on
anxiety levels. However, adaptive coping did not show any such effects. Similar findings
were reported in another study, where disengagement coping (maladaptive coping)
aggravated anxiety and depressive symptoms (Varni, Miller, McCuin, & Solomon, 2012).
Higher levels of maladaptive coping and lower levels of adaptive coping were associated
with higher levels of anxiety symptoms (Gonzalez, Solomon, Zvolensky, & Miller,
2009). Contrasting these findings, a study done among Australian PLWH showed that
adaptive coping was not associated with HIV-related stigma and anxiety (Pakenham &
Rinaldis, 2001). The variety of these conflicting findings suggest that the relationship
between stigma, anxiety and coping is very complex. Many different aspects of mental
functioning are affected by the stressors associated with the HIV-related stigma. A
number of different coping mechanisms are used to overcome these stressors (O’Donnell
et al., 2013; Gore-Felton et al., 2013). Thus, the preponderance of either one of these
factors (stressor versus coping) may affect the outcome variables such as anxiety levels.
This explains why adaptive coping may be beneficial in lowering anxiety (Pakenham &
Rinaldis, 2001), or may not show any association as observed in this study. The same
assumptions can be extrapolated to maladaptive coping, which showed adverse
associations with anxiety in this study. Coping mechanisms are inherently different with
regards to their impact on anxiety symptoms. Future interventions should therefore
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consider not only the type of coping, but also their associations with different aspects of
mental well-being. This could be achieved through improved assessment of perceived
stigma and anxiety provoking factors.
In this study, anxiety levels were adversely associated with treatment adherence.
A number of studies have shown adverse associations between anxiety disorders and
treatment adherence in several PLWH populations. For example, in a study done among
85 female PLWH from New York City, many different components of anxiety were
adversely associated with treatment adherence (Willie, Overstreet, Sullivan, Sikkema, &
Hansen, 2015). In a multivariable analysis of 358 Italian PLWH, it was found that
anxiety symptoms were significantly associated with treatment non-adherence
(Ammassari et al., 2001). In a longitudinal study of 193 Swedish PLWH, Nilsson
Schönnesson and colleagues (2007) reported that anxiety measured by the Brief
Symptom Inventory, significantly predicted suboptimal treatment adherence. Similarly,
in a Brazilian study among 293 PLWH, severe anxiety predicted treatment non-adherence
after adjusting for education, employment, and substance use in the past 4 weeks
(Campos, Guimarães, & Remien, 2010). These findings support the relevance of this
study, where associations were found between stigma, coping mechanisms and anxiety
levels, and their combined effects on treatment adherence.
Irrespective of these findings, there were some limitations to this study. This
study was cross-sectional and causal associations could not be determined. The study also
lacked an HIV-negative comparison group and therefore there could be many
confounders affecting these findings. The participants were privileged to have
comprehensive health care services from the GHESKIO centers in Haiti. They could have
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been significantly different from other PLWH in Haiti who had limited access to these
services due to several reasons. This would compromise some of the external validity of
the findings. The current study was a secondary analysis of baseline data collected for the
parent study, leading to surrogate information biases. The data is self-reported, and
participants were HIV positive alcohol users, which may have increased recall bias, and
social desirability biases could have affected the findings of this study.
Conclusion
In summary, this study showed that the maladaptive coping strategies adversely
mediated the relationship between stigma and anxiety symptoms. However, the beneficial
mediating effect of adaptive coping on these factors was not evident. Furthermore, these
adverse effects in turn potentiated the adverse effect of anxiety on treatment adherence.
Thus, this study suggests that future intervention should aim at teaching PLWH to
decrease their maladaptive coping strategies while dealing with HIV-related stigma. This
could decrease their anxiety symptoms and improve their treatment adherence.
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Table 4.1. Demographic characteristics of the participants
Characteristics
Anxiety
p value
Total
(n=285,
Low
High
100%)
(n=151,
(n=134,
52.8%)
47.2%)
Age*
37.80±8.77
34.91±8.25
.005
36.43±8.62
Gender
.008
Male
75 (49.7%)
45 (34.1%)
120 (42.3%)
Female
76 (50.3%)
89 (65.9%)
165 (57.7%)
Education*
.869
6th grade or less
86 (59.3%)
77 (58.3%)
163 (58.8%)
Some high
59 (40.7%)
55 (41.7%)
114 (41.2%)
school or higher
Marital status*
.202
Single or living
66 (43.7%)
49 (36.3%)
115 (40.2%)
as single
Married
85 (56.3%)
85 (63.7%)
170 (59.8%)
Employment
.096
Full time job
1 (1.5%)
4 (4.4%)
5 (3.2%)
Seasonal job
22 (33.8%)
15 (16.5%)
37 (23.7%)
Unemployed
32 (49.2%)
61 (67.0%)
93 (59.6%)
Student
2 (3.1%)
2 (2.2%)
4 (2.6%)
Incapacitated
1 (1.5%)
0 (0%)
1 (0.6%)
Other
7 (10.8%)
9 (9.9%)
16 (10.3%)
Income
.555
<$150
25 (29.8%)
10 (22.7%)
35 (27.3%)
$151-1,000
32 (38.1%)
16 (36.4%)
48 (37.5%)
>$1,000
27 (32.1%)
18 (40.9%)
45 (35.2%)
Primary care
.200
Yes
133 (88.1%)
124 (92.6%)
257 (90.2%)
No
18 (11.9%)
10 (7.4%)
28 (9.8%)
Note: P value corresponds to independent samples t test, chi-square test or Fisher's exact
test
*p<.05; **p<.01; ***p<.001
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Table 4.2. Participants’ stigma by anxiety level
Stigma
Anxiety
p value
Low
High
Personal
54.33±7.94
54.88±8.40
.574
Public
53.11±9.27
55.44±11.31 .060
Total
107.09±16.14 110.32±17.50 .106
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Total
54.57±8.13
54.15±10.30
108.54±16.79

Table 4.3. Participants’ Brief COPE scores by anxiety level
Brief COPE
Anxiety
Low
High
Adaptive coping
Positive reframing
4.91±1.70
5.15±1.85
Use of instrumental support
5.12±1.82
5.08±1.96
Religion
5.90±1.79
6.00±1.54
Use of emotional support
4.89±1.67
4.90±1.85
Acceptance
5.00±1.57
5.11±1.71
Planning**
5.07±1.64
5.70±1.56
Active coping*
4.95±1.76
5.41±1.83
Humor
4.64±1.65
4.88±1.85
40.52±8.95 42.26±9.40
Total adaptive coping
Maladaptive coping
Self-distraction**
Denial***
Substance use***
Behavioral disengagement***
Venting*
Self-blame***
Total maladaptive coping***
Total coping***
*p<.05; **p<.01; ***p<.001

4.59±1.64
4.54±1.71
4.11±2.01
4.83±1.84
4.85±1.73
4.90±1.92
27.84±7.55

5.29±1.79
5.51±1.74
5.21±1.71
6.08±1.84
5.36±1.77
5.92±1.82
33.41±7.46

p value

.262
.876
.653
.973
.571
.001
.034
.250
.115

5.02±1.77
5.12±1.88
5.94±1.68
4.90±1.75
5.03±1.65
5.36±1.62
5.16±1.80
4.77±1.76
41.33±9.16

.001
.000
.000
.000
.016
.000
.000

4.92±1.74
4.98±1.79
4.65±2.15
5.42±1.95
5.07±1.77
5.39±1.94
30.44±7.99

68.36±14.83 75.67±15.48 .000
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Total

71.78±15.50

Table 4.4. Participants’ treatment adherence by anxiety level
Treatment
Anxiety
p value
adherence
Low
High
Adherence*
53.11±7.96
50.15±9.04
.011
*p<.05
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Table 4.5. Correlation between anxiety, adherence, perceived stigma, and coping
1
2
3
4
5
6
1. Anxiety
--2. Adherence
-.141*
--3. Personal view
.079
-.08
--4. Public view
.132*
-.081
.562**
--5. Perceived stigma
.123*
-.093
.850**
.912**
--6. Adaptive coping
.048
-.025
-.324** -.271** -.333** --7. Maladaptive coping .398**
-.129* -.101
-0.051
-0.083
.632**
8. Total coping
-.167** .041
.182**
.148*
.184** -.586**
*p<.05; **p<.01; ***p<.001
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7

---.542**

8

---

Figure 4.1. Path diagram to describe the interrelationship between HIV related stigma,
maladaptive coping, anxiety, and HIV treatment adherence
Maladaptive Coping
.23***

.18**

Perceived stigma

.16**

Anxiety

*p<.05; **p<.01; ***p<.001
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-.14*

Adherence
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CHAPTER V: Relationships between Depression, Social Support and HIV-Related
Stigma in Alcohol Using PLWH in Haiti
Introduction
It has long been recognized that people living with HIV (PLWH) face significant
psychosocial challenges that often result in complex mental health problems (Mellins &
Malee, 2013; Petersen, et al., 2010; Tucker et al., 2004). Many studies on the health
challenges faced by PLWH identify mental health problems as one of the most common
comorbidities associated with HIV (Edmiston, Passmore, Smith, & Petoumenos, 2015;
Kendall et al., 2014). Among these, depression is the most widespread (Choi, 2013),
affecting PLWH at a rate nearly double that of the general population (Ciesla & Roberts,
2001). Even the presence of depressive symptoms that do not meet the clinical criteria for
depressive disorders result in impaired immunological responses and higher mortality
rates (Ironson et al., 2005).
One of the most significant risk factors for mental health problems (including
depression) among PLWH includes HIV-related stigma. Stigma is a complex social
process involving stereotyping, status loss, and discrimination (Mahajan et al., 2008).
HIV-related stigma has been linked to the creation and maintenance of social inequalities,
often along the lines of race, class, gender, and sexual orientation (Parker & Aggleton,
2003). This is additionally complicated by stigmas related to drug useand homosexuality
(Reidpath & Chan, 2005). Several studies have shown that HIV-related stigma is more
intense when compared to the stigmas associated with other illnesses such as herpes,
cancer, tuberculosis etc. (Hatzenbuehler, Phelan & Link, 2013; Breet, Kagee & Seedat,
2014; Crawford, 1996). Research has consistently shown that higher levels of stigma are
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associated with lower levels of mental health in PLWH (Logie & Gadall, 2009) and HIVrelated stigma is said to be one of the greatest barriers towards providing adequate
support and treatment to PLWH (Aggleton, 2002).
When faced with situations of acute/ongoing stress or the challenges of stigma
and discrimination, individuals engage in coping processes that include behavioral as
well as psychological adaptations aimed at overcoming the stressors or challenges
(Taylor & Stanton, 2007). Among PLWH, stigma constitutes an important cause of
stress, anxiety, panic and depression and PLWHs are exposed and forced to cope with it.
The notion of “resilience resources” was constructed to identify the modifiable and
strength-based moderators that have effects on the coping mechanisms adopted by
PLWH (Earnshaw et al., 2015). The characteristics associated with resilience may be
both individual (e.g. self-esteem, personality traits, coping style, spirituality, etc.) and
social (e.g. supportive peer networks, relationship and support from family, friends etc.;
Zhang et al., 2015). Research, particularly among PLWH, consistently highlights the
instrumental role played by social support in both physical and mental health outcomes
(Degroote, Vogelaers, & Vandijck, 2014). Studies show that social support is particularly
effective in coping with depression, improving treatment adherence, and retention in
treatment facilities (Yeji et al., 2014). PLWH with greater access to social support
systems experience less stigma-related stress which may ultimately protect them from
adverse HIV symptoms (Earnshaw, 2015). Evidently, more research is needed to better
understand the relationships and interactions between these core aspects of HIV-related
stigma, social support and depression.
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The current study aims to understand the relationship between depression, social
support and HIV-related stigma in a sample of HIV positive alcohol users living in
resource limited settings such as Haiti. Studying the interrelationships between these
variables will allow a greater understanding of the role played by each of these variables
in influencing the health care outcomes in PLWH.
Methods
Study Design and Population
The current study was a secondary analyses of data from the parent study entitled,
“Intervening with Haitian HIV Positive Alcohol Users: An Environmental Psychosocial
Framework.” The parent study was a randomized controlled trial that examined the
effectiveness of the adapted CBSM-A intervention in simultaneously reducing risk
behaviors, improving ART adherence and mood. Participants were provided with
information on HIV disease and its treatment, including currently available ART
medications, the negative effects of substance use and high-risk sexual behavior on the
immune system and health status, and the nature of stress and coping responses and
resources. The skill building aspects of the parent study included: teaching anxiety
reduction skills such as progressive muscle relaxation, relaxing imagery and autogenics;
modifying maladaptive cognitive appraisals using cognitive restructuring; enhancing
interpersonal conflict resolution skills and anger expression via anger management and
assertion training; and providing a supportive group environment and increase utilization
of social support networks. Data collection for the parent study occurred at the
GHESKIO (Groupe Haitien d’Etude du Sarcome de Kaposi et des Infections
Opportunistes) Centers in Port-au-Prince, Haiti. The CBSM-A intervention was designed
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to include a combination of problem-focused (e.g., active coping and planning) and
emotion-focused (e.g., relaxation training, seeking emotional support) coping strategies.
The parent study included participants who were: between18 and 60 years of age;
fluent in spoken Haitian Creole; documented HIV seropositivity; reported at least one
episode of unprotected anal or vaginal sex in the past 90 days; reported recent alcohol
consumption; were not cognitively impaired at the time of recruitment; and did not show
symptoms of any major psychiatric disorder. The current study included subjects who
participated in baseline assessments before the beginning of randomization and
interventional follow-up visits. The institutional review board (IRB) at Florida
International University approved this secondary analyses study in September, 2015.
Measures
Cognitive and Affective Symptoms of Depression
The Centers for Epidemiological Studies Depression Scale (CES-D) is a 20-item
questionnaire that assesses symptoms of depression over the past seven days (Radloff &
Locke, 1986; see Appendix III). The somatic depression items in the CES-D overlap with
HIV-related symptoms (Kalichman, Rompa, & Cage, 2000). The parent study
administered only 15 questions which measured cognitive and affective symptoms of
depression in order to limit confounding between somatic depression variables and HIV
disease-related symptoms. Somatic depression questions such as restless sleep, anorexia,
lack of energy, fatigue, and poor concentration were not included in the parent study. The
resulting 15-item questionnaire measured mood related and attitudinal aspects of
depression. Because the questionnaire was truncated to only 15 items, the original scale
could not be applied to the parent study or current study and the scale was re-categorized
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based on mean and standard deviation. Subjects were categorized as affectively depressed
if they scored greater than one SD above the mean total scores on mood related and
attitudinal aspects of depression. Cronbach’s alpha of the instrument was 0.749.
Stigma of HIV/AIDS
HIV/AIDS-related stigma was measured using the Perceived Stigma of
HIV/AIDS scale (Bauman, Camacho, Westbrook, & Forbes-Jones, 1997; Bauman,
Silver, & Camacho, 2000; Westbrook & Bauman, 1996; see Appendix I). This scale
measures stigma in terms of two components – internalized stigma and externalized
stigma. In order to measure these two parameters, the questionnaire includes two
subsections – personal view and public view. The personal view subscale includes
questions related to shame, guilt, blame, embarrassment, and poor self-worth due to HIV.
The public view subscale includes questions related to participant’s perception about
social stigma, for example, what the respondent thinks about other people's attitudes and
beliefs towards his/her disease condition. The questions in the subscales are both
positively and negatively phrased to increase the specificity of the responses. Both
subscales have 24 questions measured by four-point Likert-type scale (1 = strongly agree
to 4 = strongly disagree). The total score of each subscale ranges between 24 and 96 and
higher scores represent higher levels of personal or public stigma. Cronbach’s alpha of
the instrument was 0.867.
Social Support
Modified Medical Outcome Study Social Support Survey (mMOS-SSS) was used
to assess the levels of social support received by the participants (Sherbourne & Stewart,
1991; see Appendix VI). The mMOS-SSS questionnaire was developed to measure
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medical outcome in the year 1991 and reported good internal validity (Cronbach’s alpha
of the instrument was 0.787). This questionnaire includes an 8-item survey of perceived
availability of social support and includes two subscales – emotional/informational social
support and tangible/instrumental social support. The emotional/informational social
support subscale measures empathy, love, trust and caring received by the participants.
The tangible/instrumental social support subscale measures tangible benefits and services
received by the participants. Each of the two subscales are measured in terms of a 5-point
scale (1 = None of the time, 2 = A little of the time, 3 = Some of the time, 4 = Most of the
time, and 5 = All of the time) and the total scores range from 8 to 40 and higher scores
represents higher levels of social support.
Data Analyses
IBM SPSS Statistics (Version 23) and IBM SPSS Analysis of Moment Structures
(AMOS; Version 23) were used for data analysis (Armonk, NY: IBM Corp.).
Frequencies, means, standard deviations, t tests, chi-square tests and Fisher's exact tests
were used to describe the demographic characteristics. Independent samples t tests were
used to compare perceived stigma and social support variables between depressed and
non-depressed participants. Pearson correlations were used to find associations between
perceived stigma, depression, and social support variables. Multivariable linear
regressions were used to estimate the predictors of depression with demographics, stigma
and social support as independent variables. In the regressions analysis, crude models
were initially used and subsequently adjusted for associated covariates. The covariates
were also tested for significant associations with the outcome variable using bivariate
analysis before being incorporated into the final model. To increase the validity of the
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model, multicollinearity among covariates was tested prior to regression analyses.
Adjusted models included non-missing values for all independent variables included in
the models. Structural equation modeling (SEM) was used to test the hypothesis whether
the relationship between HIV-related stigma and depression was mediated by social
support variables. SEM accounts for multiple interactive relationships and variances and
explores for directional associations between them leading to delineation of the mediators
(Grimm & Yarnold, 2000; Kline, 1998). Maximum-likelihood estimation methods were
used for AMOS modules in the analyses. Statistical significance was set at p <0.05 for all
the analyses.
Results
Demographic and socio-economic characteristics
A total of 362 participants were included in the secondary analyses and 135
(37.0%) were men (Table 1). The mean age of the sample was 35.72±8.50 (Mean±SD)
years. Approximately 61% of the participants had a 6th grade or less education. About
58% reported that they were married and about 59.7% were unemployed. The majority of
the participants reported having primary care physicians (89.0%). Except for age, there
were no significant differences in other socio-demographic variables between depressed
and non-depressed participants.
Stigma and depression
Depressed participants reported higher levels of perceived stigma than nondepressed participants (p = .034; Table 2). Similarly, depressed participants reported
higher levels of perceived stigma-public view than non-depressed participants (p = .039).
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However, there were no significant differences in perceived stigma-personal view
between depressed and non-depressed participants.
Social Support and depression
Depressed participants reported lower levels of both components of social support
as well as total social support (emotional/informational social support, p = .002;
tangible/instrumental social support, p = .000; and total social support, p = .000; Table 3).
Relationships Between Perceived Stigma, Depression, and Social Support
Significant positive correlations were observed between depression, and total
social support (r = -0.199, p <0.01), emotional/informational social support (r = -0.162, p
<0.01), and tangible/informational social support (r = -0.189, p <0.01). Significant
negative correlations were observed between depression and perceived stigma-public
view (r = 0.104, p <0.05; Table 4).
Predictors of HIV treatment adherence
In the adjusted multivariable linear regression model, being female (Beta = 3.076,
p = .001), having lower tangible/informational social support (Beta = -0.309, p = .020),
and having higher perceived stigma-public view (Beta = 1.877, p = .037) were
significantly associated with higher levels of depression. The beta estimates and standard
errors for each of the predictors are presented in Table 5.
Mediation analysis
In the mediation analysis, coefficients for all the variables including perceived
stigma-personal view, perceived stigma-public view, emotional/informational social
support, tangible/informational social support, and depression were estimated
simultaneously. However, no significant associations were found between these variables
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in our mediator analyses. Figure 1 shows the path diagram for the variables which
showed significance in the regression analyses. In this model, there were significant
associations between perceived stigma-public view and depression (Beta = 2.398, p =
.021) and tangible/informational social support and depression (Beta = -0.412, p = .000).
However, there were no associations between perceived stigma-public view and
tangible/informational social support (Beta = 0.023, p = .531). These findings suggest
that the effect of stigma on HIV treatment adherence is not mediated by social support.
Discussion
Similar to many other populations, Haitian PLWH are exposed to challenges such
as limited social support, HIV-related stigma, and mental health problems (Vanable et al.,
2006). While these challenges are often addressed independently in many studies, our
study is unique in integrating these complex variables. Our results show that perceived
stigma-public view and tangible social support were significant predictors of depressive
symptoms. Mediation analyses, however, showed that tangible social support did not act
as a mediator between perceived stigma-public view and depressive symptoms. This
could be due to the stronger effects of perceived stigma-public view on depressive
symptoms. Social support could not alleviate the effect of stigma on depressive
symptoms.
About 45.6% of our participants reported depressive symptoms and was slightly
greater than the prevalence (41.7%) reported in the Haitian general population
(Wagenaar, 2012). Supporting the findings in our study, many other studies have reported
higher levels of clinical depression in PLWH. For example, in a study done by Nakasujja
et al. (2010) among PLWH in Uganda, about 53.9% reported higher levels of depressive
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symptoms (CES-D scores ≥16). Similarly, in a study done among Kenyan PLWH,
Monahan et al. (2009) found that about 34% of PLWH reported some form of depressive
disorders.
A significant number of our participants (47.8%) reported experiencing high
levels of perceived stigma. A number of studies have reported that PLWH experience
significant levels of perceived stigma. For example, in a study done by Kalichman et al.
(2005) among 2,306 South African PLWH, 27% believed that they were dirty, 38%
reported being ashamed of their condition, and 41% felt guilty of having acquired HIV.
Similarly, in a Ugandan study, high levels of stigma were reported by PLWH and the
levels of stigma increased over time (Chan et al., 2015).
Our study found that being female, having higher perceived stigma-public view
and lower tangible social support were associated with higher levels of depression.
Consistent with other studies, PLWH in our study who perceived being more stigmatized
reported higher levels depressive symptoms (Berger et al., 2001; Lee et al., 2002). The
strong associations between perceived stigma-public view and depressive symptoms
highlight the prominent role played by self-perceived stigma in aggravating mental health
problems. Depression is characterized by a negative pattern of thinking, in which
unfortunate events are associated with personal faults (for example, something bad
happened to me because of my own mistake), and positive events are believed to be
governed by extracorporeal forces (for example, something good happened to me because
of sheer luck). Internalized stigma reinforces depressive feelings because it characterizes
similar conceptualizations wherein unfortunate events are associated with personal faults
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(for example, one deserves to be the target of prejudice because one possesses the
discriminatory negative attribute; Peterson, 1988; Peterson, Seligman, & Vaillant, 1988).
In our study, tangible/instrumental social support significantly and negatively
predicted depressive symptoms. Tangible/instrumental social support can range from
making a meal for someone to driving that person to the doctor’s office. In some
situations, individuals need material goods or tangible actions to help them overcome
challenging circumstances (Sherbourne & Stewart, 1991). Many other studies have
highlighted the importance of tangible social support in chronic disease states. For
example, in a randomized controlled trial done in Uganda, participants who received
tangible/instrumental social support in terms of treatment support personnel had 4 times
higher odds of achieving optimum HIV treatment adherence when compared to those
without support personnel (Kunutsor, 2011). Similarly, many studies have documented a
direct relationship between tangible/instrumental social support and increased adherence
to ART (Gonzalez et al., 2004, Ulett et al., 2009 and Vyavaharkar et al., 2010). However,
similar studies associating the effects of tangible/instrumental social support in
alleviating the effects of depressive symptoms in PLWH are sparse. Nevertheless, many
studies exist about the beneficial effects of total social support (encompassing
emotional/informational and tangible/instrumental social support) in minimizing
psychological stressors in PLWH. For example, social support is particularly important in
women because they rely on social interactions and acquaintances for reliving their
stressors (Hurdle, 2001). Many studies also report inverse associations between total
social support and depression in PLWH (Catz, Gore-Felton, & McClure, 2002;
McDowell & Serovich, 2007). However, in our study, though there were inverse and
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beneficial associations between tangible/instrumental social support and depression,
similar findings were not evident for emotional/informational arm of the social support
variable.
In the current study, men relied less on social support and reported lower levels of
depressive symptoms when compared to women. This is consistent with abundant
literature on gender differences in the prevalence of depression as well as the coping
mechanisms. Women generally tend to have greater depression levels and rely more on
social support for coping with their stressors. For example, in a review about gender
differences in depression, Nolen-Hoeksema (2001) reported that women in general were
twice as likely to suffer from depression when compared to men, irrespective of
nationalities, cultural affiliations and ethnicities. In a Rwandan study on female PLWH,
women with HIV reported extremely high prevalence (81%) of depressive disorders
(Cohen, 2011). Nolen-Hoeksema et al. (1999) proposed the Response Style Theory
(RST), wherein women were more likely to ruminate in response to dysphoric or
depressive moods, reinforcing the negative spiral of acute and chronic depressive states.
Men on the contrary adopt distraction techniques to cope with depressed or dysphoric
states thereby overcoming it. These inherent gender differences in coping mechanisms
has been proposed as one of the reasons for greater prevalence of depressive disorders in
females. This could also be the reason why social support mechanisms are more relied
upon by women as a means of distraction to overcome their depressed states. However,
studies have also suggested that men resort to harmful distractions such as substance use,
risky sexual behaviors and risk seeking behaviors to overcome their dysphoric states
(McBride & Bagby, 2006).

124

Irrespective of the significant findings in the study, there are some limitations.
The parent study enrolled a consecutive convenience sample of PLWH attending the
GHESKIO centers in Haiti. This sample of frequent health care users could be
significantly different from the general population of PLWH in Haiti. As the parent study
did not employ a random sampling technique for selecting participants from the total
population of PLWH in Haiti, the findings in the current study are not generalizable,
thereby limiting the external validity. The current study constituted a secondary analyses
of variables collected for the parent study. This could be responsible for some surrogate
information biases in the current study. This study was a cross-sectional analyses of
baseline data collected for the parent study. Because of the cross-sectional nature of the
study, only associations could be derived and causal relationships could not be
established. Furthermore, this study did not have an HIV-negative comparison group to
eliminate the effects of confounders influencing the relationship between independent
and outcome variables in the study.
Conclusion
Our results suggest that comprehensive care for PLWH in Haiti should consider
the relationship between intrapersonal (e.g. depression, stigma) and interpersonal (i.e.,
social support) variables. Such efforts should also encompass gender-based adaptations to
account for the higher prevalence of depression in female PLWH. Our findings also
suggest that improving social support and reducing stigma could be very useful in
decreasing the prevalence as well as the adverse effects of depressive disorders in PLWH.
Such multilevel efforts incorporating many interrelated constructs could bring significant
changes in health status and general well-being of Haitian PLWH.
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Table 5.1. Demographic characteristics of the participants
Characteristics
Mood related and attitudinal
depression
Non-depressed
Depressed
(n=197,
(n=165,
54.4%)
45.6%)
Age
35.92±8.36
35.48±8.68
Gender**
Male
85 (43.1%)
49 (29.7%)
Female
Education
6th grade or less
Some high school or
higher
Marital status
Single or living as
single
Married
Employment
Full time job
Seasonal job
Unemployed
Student
Incapacitated
Other
Income
<$150
$151-1,000
>$1,000
Primary care
Yes

112 (56.9%)

116 (70.3%)

112 (56.9%)

109 (66.1%)

85 (43.1%)

56 (33.9%)

p
value

.629
.008

Total
(n=362,
100%)

35.72±8.50
135
(37.0%)
228
(63.0%)

.074
221
(61.0%)
141
(39.0%)
.221
77 (39.1%)

75 (45.5%)

120 (60.9%)

90 (54.5%)

152
(42.0%)
210
(58.0%)
.110

3 (3.1%)
24 (24.5%)
52 (53.1%)

2 (1.9%)
22 (21.4%)
68 (66.0%)

5 (5.1%)
0 (0%)
14 (14.3%)

0 (0%)
1 (1.0%)
10 (9.7%)

5 (2.5%)
46 (22.9%)
120
(59.7%)
5 (2.5%)
1 (0.5%)
24 (11.9%)
.807

27 (28.1%)
38 (39.6%)
31 (32.3%)

17 (27.4%)
22 (35.5%)
23 (37.1%)

173 (87.8%)

149 (90.3%)

44 (27.8%)
60 (38.0%)
54 (34.2%)
.452

322
(89.0%)
No
24 (12.2%)
16 (9.7%)
40 (11.0%)
Note: P value corresponds to independent samples t test, chi-square test or Fisher's exact
test
*p<.05; **p<.01; ***p<.001
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Table 5.2. Comparison of perceived stigma by mood related and attitudinal depression
among participants
Perceived stigma
Mood related and attitudinal
p value
Total
depression
Non-depressed
Depressed
Personal view
53.75±7.89
55.17±8.25
.095
54.39±8.07
Public view*
52.76±9.97
55.02±10.77
.039
53.79±10.38
Total*
106.51±15.80
110.19±17.16
.034
108.18±16.51
*p<.05; **p<.01; ***p<.001
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Table 5.3. Comparison of social support by mood related and attitudinal depression
among participants
Social support
Mood related and attitudinal
p value
Total
depression
Non-depressed
Depressed
Emotional/informational 12.88±3.80
11.52±4.48
.002
12.26±4.17
support**
Tangible support***
11.61±3.51
10.01±3.83
.000
10.88±3.74
Total***
24.50±6.22
21.53±7.42
.000
23.14±6.94
*p<.05; **p<.01; ***p<.001
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Table 5.4. Correlations among perceived stigma, depression, social support and demographic characteristics
1
2
3
4
5
6
7
1. Depression
--2. Perceived stigma
.085
--3. Personal view
.039
.862** --4. Public view
.104*
.919** .594** --5. Social support
-.199**
-.077
-.058
-.077
--6. Emotional/
-.162**
-.103
-.071
-.108* .891**
--informational
support
7. Tangible support
-.189**
-.028
-.028
-.022
.862**
.537** --*p<.05; **p<.01; ***p<.001
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Table 5.5. Multivariable linear regression predicting depression
Independent variables
Estimate
Standard
Beta
error
Age
.053
.051
.055
Sex**
3.076
.907
.182
Education
-1.351
.878
-.081
Marital status
-.394
.856
-.024
Primary care physician
-.390
1.323
-.015
Emotional/informational
-.124
.118
-.063
support
Tangible support*
-.309
.132
-.142
Personal view
.191
.884
.012
Public view*
1.877
.898
.115
*p<.05; **p<.01; ***p<.001
Adjusted R-squared value = .26
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p value
.302
.001
.125
.645
.769
.295
.020
.829
.037

Figure 5.1. Path diagram to describe the interrelationship between HIV related stigma,
social support and depression
Tangible support
.023

Perceived stigma – public view

-.412***
2.398**
cv

*p<.05; **p<.01; ***p<.001
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CHAPTER VI: Summary, Limitations and Future Extensions
Summary of the Study
The present study was a secondary analyses of baseline data collected from a
convenience sample of 389 alcohol using PLWH who attended the GHESKIO Centers in
Port-au-Prince, Haiti. The parent study was a randomized controlled trial that evaluated
the effectiveness of an adapted CBSM-A intervention. This secondary analyses examined
the effects of HIV-related stigma on treatment adherence and how factors like depression,
social support, coping, and anxiety mediated this relationship.
The mean age of the cohort was 35.72±8.50 (Mean±SD) years. About 37.0% were
male participants. About 59% reported a 6th grade or less level of education. More than
half of them were unemployed (59.2%). Approximately 27% of the participants reported
income less than $150 per annum. These characteristics represent the general levels of
poverty prevalent in Haiti (Farmer, 2006). Albeit, the majority of the participants
reported having primary care physicians (91.2%) strikingly higher than the health care
characteristics of PLWH in Haiti (Peck et al., 2003). The mean treatment adherence was
93.1%, and this included 100% adherence reported by 71.9% of the cohort. About 50.2%
reported high levels of total perceived stigma, 47.2% reported high levels of perceived
stigma-public view, and 48.7% reported high levels of perceived stigma-personal view.
About 58.1% received high levels of tangible/informational social support and 53.9%
received high levels of emotional/informational social support. Slightly greater than half
of all participants (51.1%) reported high levels of total coping, 50.2% reported high
levels of adaptive coping, and 51.6% reported high levels of maladaptive coping. About
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45.6% reported clinical depression and 47.2% reported clinically significant symptoms
for the state anxiety.
Significant positive correlations were observed between treatment adherence and
satisfaction of quality of care scores (p <0.01). Many studies have documented that
treatment adherence is improved by increasing the quality of health care through higher
levels of comprehensiveness, competence, continuity of care, consistency, and
compassion demonstrated by the health care personnel during clinical encounters
(Bristow, Chang, Ziogas & Anton-Culver, 2013; Ratanawongsa et al., 2013; Williams &
Friedland, 1997). Higher levels of anxiety were associated with higher levels of total
perceived stigma (p <0.05), perceived stigma-public view (p <0.05), and maladaptive
coping (p <0.01). Similar associations were observed in other studies where higher levels
of anxiety and other psychiatric disorders were associated with higher levels of stigma
and maladaptive coping mechanisms (Alonzo & Reynolds, 1995; Gonzalez, Solomon,
Zvolensky & Miller, 2009; Varni, Miller, McCuin & Solomon, 2012).
Significant negative correlations were observed between treatment adherence and
total perceived stigma (p <0.05), maladaptive coping (p <0.05), and anxiety levels (p
<0.05). Stigma, maladaptive coping, and anxiety levels have adversely affected treatment
adherence in similar other studies (Katz et al., 2013). In the current study, we found that
higher levels of perceived stigma-public view (p <0.05), lower levels of total social
support (p <0.01), emotional/informational social support (p <0.01) and
tangible/informational social support (p <0.01) were associated with higher levels of
depression. In the adjusted multivariable linear regression model predicting depression,
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being female (p = .001), having lower tangible/informational social support (p = .020),
and having higher perceived stigma-public view (p = .037) were significantly associated
with higher levels of depression. In the adjusted multivariable linear regression model for
predicting HIV treatment adherence, perceived stigma (p = .031), showed significant
negative associations with treatment adherence, whereas, satisfaction of quality of care
scores (Beta = .032, p = .041) showed positive association with treatment adherence. A
number of studies have demonstrated the determinants of depression which include
stigma, female gender, and lack of social support in several other populations (Simbayi et
al., 2007; Li, Lee, Thammawijaya, Jiraphongsa & Rotheram-Borus, 2009). In addition,
studies have also documented that these factors adversely affected treatment adherence
(Rintamaki, Davis, Skripkauskas, Bennett & Wolf, 2006; Uthman, Magidson, Safren &
Nachega, 2014; Horvath et al., 2013).
In the mediation analysis looking for the mediator effects of maladaptive coping
on the relationship between stigma and anxiety, there were significant associations
between perceived sigma and coping (Beta = .175, p = .003), perceived sigma and
anxiety (Beta = .164, p = .005), coping and anxiety (Beta = .229, p <.001), and anxiety
and treatment adherence (Beta = -.140, p = .018). These observations suggest that
maladaptive coping acted as a mediator between stigma and anxiety levels which in turn
had significant effects on treatment adherence. However, in the mediation analysis
looking for the mediator effects of maladaptive coping on the relationship between HIVrelated stigma and treatment adherence, there were no significant mediator effects.
Similarly, in the mediation analysis looking for the mediator effects of social support on
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the effects of stigma on depression, there were no significant mediator effects. The lack
of mediating effects could be due to the limited variability associated with only using
baseline data as well as participants using the GHESKIO Centers in Haiti. Further
longitudinal studies could unfold these associations.
Strengths and Limitations
The greatest strength of our study is in filling the gap in literature on the
associations between stigma, depression, anxiety, coping, social support and treatment
adherence among PLWH in Haiti. For the first time, we identified that maladaptive
coping mediated the relationship between stigma and anxiety in Haitian PLWH
population. A number of associations were found in the study between outcome variables
such as treatment adherence, depression and anxiety opening up newer hypothesis for
further long term experimental studies in this population. The current study will serve as
a link joining the findings in other studies applied to the Haitian PLWH population.
Irrespective of many salient findings, this study had certain limitations. The
parent study recruited a convenience sample of HIV positive participants attending the
GHESKIO Centers in Haiti. The parent study was a randomized controlled trial and had
an experimental and control arm thereby eliminating this selection bias. However, the
current study only cross-sectionally analyzed baseline data of the parent study and did not
have a control group. This group of participants attended the GHESKIO Centers and
complied with the rules and protocols of the parent study and did not absolutely represent
the entire population of disadvantaged and resource poor HIV positive participants in
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Haiti. Thus, the results of the current study cannot be extrapolated to the entire
population, thereby compromising some of its external validity.
This study included only participants reporting ART and did not include ART
naive participants. Thus, the results observed in this dissertation cannot be generalized to
the entire population of HIV positive individuals in Haiti, because only 53% of all HIV
positive patients in Haiti receive ART (UNICEF, 2013). Longitudinal studies and clinical
trials can establish causal relationships, whereas the current dissertation was a crosssectional study and enabled an examination of only existing associations at a point in
time and causal associations could not be determined.
Data used for the current study were collected for the specific aims of the parent
study and would not have absolutely complied with the specific aims of the current study.
This could be responsible for some surrogate information biases in the current study. The
variables that were collected in the parent study were secondarily analyzed and adjusted
in the current study. There could be a number of other unaccounted factors affecting the
outcome variables in the current study. However, the current study is a secondary
analysis and the confounders cannot be estimated, thus limiting the results of the study.
The majority of the questionnaires including the CPCRA Antiretroviral
Medication Self-Report questionnaire, Perceived Stigma of HIV/AIDS, STAI, Brief
COPE, mMOS-SSS, and CES-D were self-reported questionnaires and therefore
susceptible to memory and recall biases. These questionnaires are also susceptible to
social desirability bias wherein the participants respond to the questions in a favorable
and socially desirable ways. This bias interferes with the interpretation of average
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tendencies and individual differences. Such biases could decrease the internal validity of
the study.
Future Extensions
PLWH often have complicated past histories including depression, anxiety,
stigmatic experiences, and inadequate social support (Vyavaharkar et al, 2010; Charles et
al., 2012). These factors can adversely affect treatment adherence, risk behaviors, and
quality of life. Outcomes from this study may be informative in developing successful
strategies for stigma, coping, anxiety and depression and planning effective interventions
for improving treatment adherence in HIV positive populations. The findings in this
study may significantly contribute towards fueling future research on the same topic. This
cross-sectional analyses may serve as a basis for future large scale studies on the
association between stigma and treatment adherence. Several other factors that could not
be measured in this study can be progressively determined, measured and analyzed in
future large scale longitudinal and randomized trials. Successive large scale research on
this topic can help in stimulating empowerment programs and legislation, thereby
empowering HIV-positive community against stigma and discrimination. Healthcare
providers should be made aware that anxiety, depression, coping and stigma could act as
barriers and should be addressed in any standard HIV care services. This can alleviate the
already failing health conditions of these patients due to impoverishment and natural
disasters and contribute to significant immune recuperation and general well-being.
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Appendix I
Perceived Stigma of HIV/AIDS
Perceived Stigma of HIV/AIDS: Personal View
Let's go over the instructions together.
[READ INSTRUCTIONS TOGETHER.]
Let's do the first item together.
[GO OVER THE FIRST ITEM.]
If you have any questions, please feel free to ask me.
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Agree

Disagree

Strongly
Disagree

1. When people know I have HIV I feel
uncomfortable around them.
2. I feel ashamed that I have HIV.
3. Because I have HIV, I should not take care of other
people's children.
4. I have been brave in handling my HIV.
5. I must have done something to deserve getting
HIV.
6. I should not share dishes or glasses just in case
someone might catch HIV from me.
7. If I applied for a job, and someone else also applied
who did not have HIV, the employer should hire the
other person.
8. Although I have HIV, I am a person who deserves
as much respect as anyone else.
9. I feel that it was my fault that I got HIV.
10. People are right to be afraid of me because I have
HIV.
11. Because of my HIV, I feel I am less attractive to
those who might want to date me.
12. I have a lot to teach people about life through
having HIV.

Strongly
Agree

Here are some statements that people with HIV have made about themselves. For each
statement, circle the answer that comes closest to the way you feel about yourself.
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13. I am embarrassed about having HIV.
14. I feel it is completely safe for me to care for other
people’s children even though I have HIV.
15. I deserve a lot of credit for how well I have coped
with HIV.
16. I feel guilty about having HIV.
17. I agree with mothers who do not want their children
to play with my children because of my HIV.
18. I understand why people would reject my
friendship because I have HIV.
19. I think I am a person of good moral character.
20. I feel ashamed about the way I got HIV.
21. Because of my HIV, I should not hold a new infant.
22. My neighbors would be right to be upset if they
learned I had HIV.
23. I think less of myself because I have HIV.
24. I think that my getting HIV was just a matter of bad
luck.
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Perceived Stigma of HIV/AIDS: Public View
Let's go over the instructions together.
[READ INSTRUCTIONS TOGETHER.]
Let's do the first item together.
[GO OVER THE FIRST ITEM.]
If you have any questions, please feel free to ask me.

Strongly
Agree

Agree

Disagree

Strongly
Disagree

The general public has a wide range of beliefs about people who have AIDS or HIV.
Here is a list of some examples of these beliefs and attitudes. For each statement, circle
the answer that best describes what you think other people's beliefs and attitudes are
about HIV.

1. Most people believe that if you have HIV, you must
have done something to deserve it.
2. Most people are afraid to be around a person with
HIV.
3. Most people are uncomfortable around people who
have HIV.
4. Most people think less of a person who has HIV.
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5. Most people think that people with HIV are of good
moral character.
6. Most people think that someone with HIV should
not take care of
7. other people's children.
8. Most people think that people with HIV deserve
respect as much as anyone else.
9. Most people feel that if you have HIV, it is your
own fault.
10. Most mothers would allow their children to play
with a child whose mother has HIV.
11. Most people would reject the friendship of a person
with HIV.
12. Most people think that if you have HIV you are not
as good as everyone else.
13. Most people think you should be embarrassed about
having HIV.
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14. Most people would not share dishes or glasses with
someone who has HIV because they are afraid they
will catch it.
15. Most people would be upset if someone with HIV
moved in next door.
16. Most people believe that having HIV is something
to be ashamed about.
17. Most people think that people with HIV should be
admired for their bravery in the face of the illness.
18. Most people think that people with HIV should feel
guilty about it.
19. Most mothers would not want someone with HIV to
hold their new infant.
20. Most people feel less attracted (as a date) to
someone with HIV.
21. Most people believe that people with HIV deserve a
lot of credit for how well they cope with the
disease.
22. Most people feel that how you get HIV is
something to be ashamed about.
23. Most people think that getting HIV is just a matter
of bad luck.
24. Most employers would hire someone with HIV to
work for them.
25. Most people think that people with HIV can teach
us a lot about life.
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The Perceived Stigma of HIV/AIDS (Bauman, Camacho, Westbrook, & ForbesJones, 1997; Bauman, Silver, & Camacho, 2000; Westbrook & Bauman, 1996) scale is
based on the conceptualization of stigma as having internalized as well as externalized
components. The authors, Westbrook and Bauman, hypothesize that stigma will cause
greater distress and lower self-esteem when the stigmatizing beliefs of others, the
externalized dimension, is internalized. The instrument has two scales. The Perceived
Stigma of HIV/AIDS: Personal View subscale is a 24-item instrument including stigma
items that reflect shame, guilt, blame, embarrassment, and poor self-worth because of
HIV. The Perceived Stigma of HIV/AIDS: Public View subscale contains 24 items
designed to obtain the participant’s perception of social stigma, i.e., what the respondent
thinks other people's attitudes and beliefs are about HIV.
The items are phrased positively and negatively, and respondents indicate level of
agreement on a four-point Likert-type scale (1=Strongly agree to 4=Strongly disagree).
On the Personal View scale, recode items 1-3, 5-7, 9-11, 13, 16-18, and 20-24 as (4=1)
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(3=2) (2=3) (1=4) and on the Public View subscale reverse items 1-4, 6, 8, 10-15, 17-19,
21-22. Sum the item values to create the subscale score. You may use mean substitution
for missing items. Higher subscale scores indicate a higher level of personal or public
stigma.
References
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Community Programs for Clinical Research on AIDS (CPCRA) Adherence SelfReport Questionnaire
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Some or a little of
the time (1-2 days)

Occasionally or a
moderate amount
of time (3-4 days)

Most or all of the
time (5-7 days)

1. How often did you feel bothered by
things that don't usually bother you?
2. How often did you feel that you could
not shake off the blues even with help
from family or friends?
3. How often did you feel that you were
just as good as other people?
4. How often did you feel depressed?
5. How often did you feel hopeful about
the future?
6. How often did you feel that your life
had been a failure?
7. How often did you feel fearful?
8. How often did you feel happy?
9. How often did you talk less than usual?
10. How often did you feel lonely?
11. How often did you feel that people
were unfriendly?
12. How often did you enjoy life?
13. How often did you have crying spells?
14. How often did you feel sad?
15. How often did you feel that people
disliked you?

Rarely or none of
the time (<1 day)

Center for Epidemiological Studies - Depression (CES-D)
Affective Depression (15-item)
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Appendix IV
Brief COPE
I haven't
been
doing
this at all
1. I've been turning to work or other
activities to take my mind off things.
2. I've been concentrating my efforts on
doing something about the situation
I'm in.
3. I've been saying to myself "this isn't
real.".
4. I've been using alcohol or other drugs
to make myself feel better.
5. I've been getting emotional support
from others.
6. I've been giving up trying to deal
with it.
7. I've been taking action to try to make
the situation better.
8. I've been refusing to believe that it
has happened.
9. I've been saying things to let my
unpleasant feelings escape.
10. I’ve been getting help and advice
from other people.
11. I've been using alcohol or other drugs
to help me get through it.
12. I've been trying to see it in a different
light, to make it seem more positive.
13. I’ve been criticizing myself.
14. I've been trying to come up with a
strategy about what to do.
15. I've been getting comfort and
understanding from someone.
16. I've been giving up the attempt to
cope.
17. I've been looking for something good
in what is happening.
18. I've been making jokes about it.
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I've been
doing this
a medium
amount

1

I've
been
doing
this a
little bit
2

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1
1

2
2

3
3

4
4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

3

I've
been
doing
this a
lot
4

19. I've been doing something to think
about it less, such as going to
movies, watching TV, reading,
daydreaming, sleeping, or shopping.
20. I've been accepting the reality of the
fact that it has happened.
21. I've been expressing my negative
feelings.
22. I've been trying to find comfort in my
religion or spiritual beliefs.
23. I’ve been trying to get advice or help
from other people about what to do.
24. I've been learning to live with it.
25. I've been thinking hard about what
steps to take.
26. I’ve been blaming myself for things
that happened.
27. I've been praying or meditating.
28. I've been making fun of the situation.

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1

2

3

4

1
1

2
2

3
3

4
4

1

2

3

4

1
1

2
2

3
3

4
4

Scales are computed as follows (with no reversals of coding):
1. Self-distraction, items 1 and 19 (Maladaptive Coping)
2. Active coping, items 2 and 7 (Adaptive Coping)
3. Denial, items 3 and 8 (Maladaptive Coping)
4. Substance use, items 4 and 11 (Maladaptive Coping)
5. Use of emotional support, items 5 and 15 (Adaptive Coping)
6. Use of instrumental support, items 10 and 23 (Adaptive Coping)
7. Behavioral disengagement, items 6 and 16 (Maladaptive Coping)
8. Venting, items 9 and 21 (Maladaptive Coping)
9. Positive reframing, items 12 and 17 (Adaptive Coping)
10. Planning, items 14 and 25 (Adaptive Coping)
11. Humor, items 18 and 28 (Adaptive Coping)
12. Acceptance, items 20 and 24 (Adaptive Coping)
13. Religion, items 22 and 27 (Adaptive Coping)
14. Self-blame, items 13 and 26 (Maladaptive Coping)

156

Appendix V
State-Trait Anxiety Inventory (STAI) Form Y-1
Please provide the following information:
Name: ___________________________________ Date: ___________
___________
Age: _______________ Gender (Circle): M F
T: _______

S:

157

Somewhat

Moderately so

Very much so

1. I feel calm
2. I feel secure
3. I am tense
4. I feel strained
5. I feel at ease
6. I feel upset
7. I am presently worrying over possible misfortunes
8. I feel satisfied
9. I feel frightened
10. I feel comfortable
11. I feel self-confident
12. I feel nervous
13. I am jittery
14. I feel indecisive
15. I am relaxed
16. I feel content
17. I am worried
18. I feel confused
19. I feel steady
20. I feel pleasant

Not at all

DIRECTIONS: A number of statements which people have used to describe themselves
are given below. Read each statement and then circle the appropriate number to the right
of the statement to indicate how you feel right now, that is, at this moment. There are no
right or wrong answers. Do not spend too much time on any one statement but give the
answer which seems to describe your present feelings best.

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3

4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4

State-Trait Anxiety Inventory for Adults Scoring Key (Form Y-1)
Developed by Charles D. Spielberger in collaboration with R.L. Gorsuch, R. Lushene,
P.R. Vagg, and G.A. Jacobs

Somewhat

Moderately so

Very much so

1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.

Not at all

To use this stencil, fold this sheet in half and line up with the appropriate test side, Form
Y-1. Simply total the scoring weights shown on the stencil for each response category.
For example, for question # 1, if the respondent marked 3, then the weight would be 2.
Refer to the manual for appropriate normative data

4
4
1
1
4
1
1
4
1
4
4
1
1
1
4
4
1
1
4
4

3
3
2
2
3
2
2
3
2
3
3
2
2
2
3
3
2
2
3
3

2
2
3
3
2
3
3
2
3
2
2
3
3
3
2
2
3
3
2
2

1
1
4
4
1
4
4
1
4
1
1
4
4
4
1
1
4
4
1
1
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Appendix VI
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A little of the
time
Some of the time

Most of the time

All of the time

Emotional/Informational Support
1. Would someone be available to talk to you if
you were upset, nervous or depressed?
2. Is there someone you could contact if you
wanted to talk about an important personal
problem you were having?
3. Would the people in your personal life give
you information, suggestions, or guidance if
you needed it?
4. Is there someone you could turn to if you
needed advice to help make a decision?
Tangible Support
5. Is there someone who would help take care
of you if you had to stay in bed for several
weeks?
6. Is there someone you could turn to if you
needed to borrow $10, get a ride to the
doctor, or some small immediate help?
7. Is there someone you could turn to if you
needed to borrow several hundred dollars for
a medical emergency?
8. Is there someone who could take care of
your children if you got sick?

None of the time

Modified Medical Outcomes Study Social Support Survey (mMOS-SSS)

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5
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